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Abstract 
Trichosanthin (TCS) is found in the root tuber of Trichosanthes kirilowii Maximowicz 
of the Cucurbitaceae family. It is a type I ribosome-inactivating protein (RIP) and 
carries out RNA N-glycosidase activity by depurinating the A4324 of the 28s rRNA. 
Recently, TCS has been found to interact with ribosomal proteins PO and PI by yeast 
two-hybrid screening and ribosomal protein P2 by in vitro binding assay. PO forms a 
P-complex (P0(P1)2(P2)2) with the dimers of PI and P2 and the P-complex constitutes 
the stalk of large ribosomal subunit. This stalk interacts with elongation factors and is 
involved in the elongation step of protein synthesis. It has also been found that 
eukaryotic elongation factor 2 (eEF2) binds to PI and P2. Then eEF2 exerts GTPase 
activity and catalyses the translocation of peptidyl-tRNA from the A to P site of the 
ribosome. 
The interaction of TCS and P-proteins raises the interest of the importance, whether 
there is a correlation with TCS biological activity and the possibility that TCS 
competes with eEF2 for the binding to P-complex before it carries out the 
ribosome-inactivating activity. 
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By protein engineering, the putative P2 interaction sites on ICS were mutated and the 
biological activity of the variants and their binding ability with P2 were assayed. 
Besides, truncation mutants of P2 were generated to map the regions that interact with 
TCS and eEF2. 
The results suggest that the C-terminal region of P2 is involved in the interaction 
between TCS and eEF2. The last five amino acids residues are essential for the 
interaction between TCS and P2 and the interaction with eEF2 required the last 36 
amino acids at the C-terminal. By Surface Plasmon Resonance and 
ribosome-inactivating assay, LI80 was found not to be the interaction site with P2 and 
its mutation to alanine showed no effect on ribosome-inactivating activity of TCS. 
Although the C-terminal region of P2 is important for the binding with TCS by both 
in vitro binding assay and NMR experiment observation, a peptide containing the last 
17 amino acids of C-terminal region of P2 has no inhibitory effect on TCS ribosome 
inactivating activity in an in vitro protein synthesis system. 
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摘要 
天花粉蛋白(trichosanthin, TCS)是從萌蘆科栝樓 ^yichosanthes kirilowii M^i^movAci) 
根室提取的I型核糖體抑活蛋白（ribosome-inactivating protein, RIP)。該蛋白有核糖 
核酸N-糖苷酶活性（RNAN-glycosidase activity)，並作用於28s核糖體腺嘌哈4324 
(A4324)�最近硏究人員從酵母雙雜交體系統（yeast two-hybrid system)發現TCS與 
核糖磷體蛋白（ribosomal phosphoprotein) PO及PI有相互作用。另外’體外結合測 
定 如 b i n d i n g assay)結果也證實TCS與核糖磷體蛋白P2具相互作用。 
P0 與 P1 及 P2 的二聚體（P1/P2 dimer)組成 P-複合物（P-complex，P0(P1)2(P2)2)並 
構成60S核糖體顆粒的楚部組織°此莖部組織與延長因子(elongation factors)的相 
互作用對製造蛋白質（protein synthes is )至爲重要。真核生物的延長因子2 
(eukaryotic elongation factor 2, eEF2)與PI及P2相互作用激發eEF2的鳥苷三磷酸 
酶活性（GTPase activity)並催化肽酰 tRNA (peptidyl-tRNA)的氣酰基部位(A-site) 
至肽酰基部位（P-site)的易位（translocation)� 









之外’應用表面等離子共振技術（surface plasmon resonance, SPR)及核糖體抑活活 
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aa Amino acid 
BSA Bovine serum albumin 
dNTP Deoxynucleoside 5' triphosphate 
EF Elongation factor 
GdnHCl Guanidine-hydrochloride 
HIV Human immunodeficiency virus 
IPTG Isopropyl P-D-thiogalactopyranoside 
ITC Isothermal titration calorimetry 
Ka • Association equilibrium constant 
kcat Turnover number 
Kd Dissociation equilibrium constant 
kDa Kilodalton 
MBP Maltose binding protein 
MMC Momorcharin 
NMR Nuclear magnetic resonance 
nt Nucleotide 
PAP Pokeweed antiviral protein 
RIP Ribosome-inactivating protein 
RTA Ricin A-chain • 
SPR Surface plasmon resonance 
TCS Trichosanthin 
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Naming system for mutant proteins 
TCS I121A Mutation of isoleucine at position 121 of TCS to 
alanine 
TCS K177AL180A Double mutation of lysine to alanine at position 177 and 
leucine to alanine at position 180 of TCS 
TCS L180A Mutation of leucine at position 180 of TCS to alanine 
TCS N236A Mutation of asparagines at position 236 of TCS to 
alanine 
P2C1 Deletion of the last aa residue at C-terminus of P2 
P2C2 Deletion of the last 2 aa residues at C-terminus of P2 
P2C3 Deletion of the last 3 aa residues at C-terminus o fP2 
P2C4 Deletion of the last 4 aa residues at C-terminus of P2 
P2C4 Deletion of the last 4 aa residues at C-terminus of P2 
P2C5 Deletion of the last 5 aa residues at C-terminus of P2 
P2C17 Deletion of the last 17 aa residues at C-terminus of P2 
P2C28 Deletion of the last 28 aa residues at C-terminus o fP2 
P2C46 Deletion of the last 46 aa residues at C-terminus of P2 
MBP-C17 C-terminal fusion of last 17 aa residues of P2 to MBP 
protein 
MBP-C29 C-terminal fusion of last 29 aa residues of P2 to MBP 
protein 
MBP-C36 C-terminal fusion of last 36 aa residues of P2 to MBP 
protein 
13 ‘ 
Abbreviations for amino acids 
A Ala Alanine 
B Asx Asparagine or aspartate 
C Cys Cysteine 
D Asp Aspartate 
E Glu Glutamate 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I He Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gin Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
X - Unknown or non-standard 
amino acid 
Y Tyr Tyrosine 
Z Glx . Glutamine or glutamate 
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Chapter 1 Introduction 
Trichosanthin (TCS) is the active component of the Chinese medicinal herb Tian Hua 
Fen (THF). TCS is extracted from the root tuber of Trichosanthes kirilowii 
Maximowicz of the Cucurbitaceae family. Recorded in the Compendium of Materia 
Medica written by Li Shi-Zhen in the late century, THF was used as a drug that 
resets menstruation and expels retained placentae. In the early 1970s, TCS was 
isolated and used to terminate early and mid-trimester pregnancies, to treat ectopic 
pregnancies, hydatidiform moles and trophoblastic tumors [Jin, 1995], Besides, TCS 
also possesses immunomodulatory, anti-tumor and anti-human immunodeficiency 
virus (anti-HIV) properties [Shaw et al, 1994]. 
TCS is a basic protein with pi 9.4 and has a molecular weight of 27 kDa. It is devoid 
of carbohydrate and phosphate group. It has no cysteine residue and therefore no 
disulfide bond [Wang et al, 1986]. The cDNA of TCS has been cloned and 
characterized [Shaw et al, 1991]. It encodes for a polypeptide of 289 amino acid 
residues that includes an N-terminal signal peptide of 23 amino acid residues and a 
C-terminal propeptide of 19 amino acid residues. After post-translational processing, 
the mature TCS consists of 247 amino acid residues. The mature protein has been 
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expressed to high level in E. coli [Zhu et al’ 1992]. This allows high level purification 
that makes structural and functional studies of TCS possible. 
TCS is a single chain polypeptide possessing N-glycosidase activity and classified as 
type I ribosome-inactivating protein (RIP). Like other RIP, such as ricin A chain, TCS 
inhibits protein synthesis by a very specific N-glycosidase activity which cleaves a 
single adenine base at position 4324 of 28S rRNA or position 2660 of 23S rRNA of 
eukaryotic or prokaryotic ribosome respectively. The depurination activity is believed 
to disrupt the conformation of 28S or 23 S rRNA and its interaction with elongation 





Fig. 1.1 The sarcin/ricin loop (SRL) structure from 28S rRNA (with corresponding 
number for E. coli 23S rRNA in parenthesis). A4324 in SRL is the reaction site for 
TCS N-glycosidase activity [Correll et al, 1998]. 
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1.1 Structure-function relationship of trichosanthin 
RIPs are highly homologous in amino acid sequences and tertiary structures. The 
crystal structure of TCS has been determined at 1.88 人 resolution [Zhou et al, 1994]. 
The TCS molecule consists of two distinctive domains. The large domain (amino acid 
1-181) contains six alpha-helices, a six-stranded sheet, and an anti-parallel beta-sheet. 
The small domain (amino acid 182-247) contains an anti-parallel beta-sheet and a 
kinked alpha-helix which is the longest helix in TCS. (Fig. 1.2) The crystal structure 
of TCS superimposes on those of ricin A-chain [Mlsna et al, 1993] and 
alpha-momorcharin (a-MMC) [Huang et al, 1995] well, indicating that their 
structures are homologous although they originate from plants of different species. 
Based on the three-dimensional structure, the putative active site of TCS was found to 
locate at amino acid residues 110-174. The deletion of the first 100 amino acids from 
TCS does not affect much on its biological activity [Ke et al, 1997]. Positions 
120-123 of TCS are found to be important for its biological activity. Deletion or 
, hydrophobic replacement of position 120-123 make the derivative has a 4000-fold 
decrease in ribosome inactivating activity [Nie et al, 1998]. By sequence homology of 
RIPs, glutamate 160 was found to be crucial in catalytic reaction. Mutation of El 60 to 
18 
alanine causes a decrease in 15-fold in activity. E189A has no significant change in 
ribosome inactivating activity of TCS but the double mutant E160A-E189A reduces 
the activity by 1800-fold. This is because E189 may substitute the role of E160 and 




Fig. 1.2 Structure of TCS. The large N-terminal domain (amino acid 1-181) is 
coloured in red, the small C-terminal domain (amino acid 182-247) is coloured in 
green and the largest alpha-helix (amino acid 182 - 204, coloured in light green) is 
bent. 
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1.2 Properties of acidic ribosomal P-proteins 
Eukaryotic ribosomes are large ribonucleoprotein complexes of about 4.5MDa 
responsible for accurate translation of the genetic material into proteins [Ibba and Soil, 
1999]. It is composed of two subunits, the small 40S subunit and the large 60S 
subunit. In the large ribosomal subunit, there is a distinct lateral protuberance known 
as "stalk". This stalk consists of highly conserved small ribosomal proteins with an 
isoelectric point in the very acidic range [Bielka, 1982], thence the name "acidic 
ribosomal proteins". Since these proteins can be phosphorylated by several protein 
kinases, such as casein kinase II, they are named as ribosomal phosphoproteins 
[Zinker et al, 1976]. 
In the stalk, two copies of PI and P2 (11.5 kDa) are found in tight connection with a 
single copy of PO (34.2 kDa) [Tchorzewki, 2002], forming a pentameric complex as 
P0(P1-P2)2. The complex binds to the 28S rRNA in the region called sarcin/ricin loop 
(SRL) which is important during elongation cycle [MacConnell and Kaplan, 1982; 
Uchiumi et al, 2002] 
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P-complex has a homologue in prokaryotic and yeast ribosome. In prokaryotes, the 
dimer of the acidic stalk protein is termed L7/L12, homologue of P1/P2, anchors to 
another protein LIO, the homologue of PO. The L10-L7/12 complex binds to the 
sarcin/ricin loop of the ribosome (GTPase center) to carry out its function in 
translation. In yeast, 
two subtypes of PI and P2 - P la /Pip , P2a/P2p are reported [Ballesta et al, 2000]. 
P l a binds with P2p while Pip with P2a forming P0(PlaP2p/PipP2a) complex 
[Ballesta et la, 2002]. 
Recent studies showed that P2 proteins do not bind to the ribosome and, instead, 
accumulate free in the cytoplasm in yeast mutants lacking both PI proteins [Remacha 
et al, 1992]. Besides, the interaction of the P1/P2 heterodimers with PO seems to take 
place through the PI component, as P2 proteins apparently show a lower affinity for 
PO [Laliot et al, 2002]. 
In E. coli, protein L7 is identical to N-terminally acetylated L12 and these proteins are 
generally referred as L7/L12. Four molecules of this acidic protein are present in each 
ribosome and exist as two dimers. The L7/L12 dimers bind to ribosomal protein LIO 
forming a pentameric complex called L8 complex [Pettersson et al’ 1976]. 
22 
L7/L12 sequences are highly homologous among eubacteria. However, they have no 
detectable sequence homology to sequences in archaea and eukaryotes, which, on the 
other hand, are clearly homologous to each other. This explains the replacement of L8 
complex in E, coli ribosomes with the rat P-protein complex changes its binding 
specificity from prokaryotic elongation factor G (EF-G) to eEF2 dependent GTPase 
activity. 
P proteins share high sequence homology. For human P-proteins, PO shares 14% and 
17% sequence identity with PI and P2 respectively, whereas PI and P2 share 38% 
identity. The C-terminal regions of them are highly conserved and the last 17 
C-terminal amino acids sequences are nearly identical. (Fig. 1.3) 
The structure of the P-complex is still unknown. Recently, the N-terminal 
poly-His-tagged rat P2 protein (1-65 amino acids) has been overexpressed and 
crystallized [Mandelman et al, 2002]. 
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1.3 Interaction among P-proteins and trichosanthin 
To find out the interacting partner of TCS, yeast two-hybrid system was used. The 
TCS mutant E160A-E180A, which has an 1800-fold reduction in in vitro 
ribosome-inactivating activity, was used to screen the MATCHMAKER cDNA 
libraries prepared from both human placenta and human T-cell leukemia vims 
(HTLV)-transformed T-cell line SLB-1, using the MATCHMAKER yeast two-hybrid 
system. About 3 million clones from both libraries were screened and 147 clones were 
identified to be PO, whereas 12 clones were identified as PI [Chan et al, 2001]. 
In vitro binding assay (section 2.4.2) was used to confirm the binding using 
TCS-coupled NHS column. Purified PO and PI bound to TCS column were detected 
in the elution [Chan et al, 2001]. To study whether TCS interacts with P2, P2 was 
overexpressed and purified for the in vitro binding assay. It is found that P2 binds to 
TCS and is detected in the elution from TCS-coupled column (Chan S.B. et al, 
unpublished data). This reveals TCS interacts with P-proteins and the interaction may 
hinder the binding of elongation factors during translation. 
-J 
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1.4 Properties of eukaryotic elongation factor 2 and interaction 
with P-proteins 
In the elongation cycle of protein synthesis, the deacylated tRNA binds to the 
70S/80S ribosome in the P/E hybrid state and the peptidyl-tRNA in the A/P hybrid 
state after the formation of the peptide bond. This pre-translocational intermediate is 
believed to be the substrate of the translocase, which is elongation factor G (EF-G) in 
bacteria and elongation factor 2 (eEF2) in eukaryotes and archaea. 
EF-G/eEF2 catalyzes the complete translocation of the deacylated tRNA and 
peptidyl-tRNA into the E- and P-sites, respectively. In addition, the mRNA advances 
by three bases, thereby exposing the next codon in the A-site. The elongation factor 
hydrolyzes one molecule of GTP during translocation. 
After translocation, the translocase leaves the ribosome allowing the ternary complex 
of EF-Tu-GTP-aa-tRNA/eEF 1 A-GTP-aa-tRNA to enter the ribosome and repeat the 
elongation cycle. 
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To exert the GTPase activity, eEF2 needs to bind to the GTPase center, which 
contains the lateral stalk P-protein complex, the GTPase-associated domain of 28S 
rRNA (1030 - 1127 in domain II of 23S rRNA) [Shimizu et al, 2002] and the 
sarcin/ricin loop of 28S rRNA (A4308 - U4339 in rat 28S rRNA ) (Fig. 1.1) 
[Szewczak et al, 1993]. The GTPase center plays an important role in 
kingdom-specific interaction between 80S ribosome and eukaryotic elongation factors. 
Eukaryotic EF2 only functions when it binds to P-proteins of eukaryotic ribosome 
[Vard et al, 1999]. However, eEF2 also functions in a hybrid ribosome in which the 
proteins at the GTPase center of the E. coli ribosome (L10-L7/L12 and L l l ) are 
replaced with the rat counterparts (P0(P1-P2)2 and RL12) [Shimizu et al, 2002; 
Uchiumi et al, 2002a&b]. This shows that eEF2 interacts with the P-complex 
functionally. 
Other experiments also showed that eEF2 binds P-proteins. For example, eEF2 
protects the GTPase-associated center in 28S rRNA to which the acidic proteins bind 
[Holmberg and Nygard，1994; Uchiumi and Kominami, 1994]. The factor has been 
chemically cross-linked to mammalian PO and P2 proteins on the ribosome [Uchiumi 
et al, 1986] and anti-P-protein antibodies are known to block eEF2 binding [Uchiumi 
et al, 1990]. By surface plasmon resonance technique, both rat PI and P2 were found 
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to interact with eEF2 in vitro, with a higher affinity for PI (Kd = 3.8 x 10'^  M) than 
that for P2 (Kd = 2.2 x 10"^  M) [Bargis-Surgey et al, 1999]. 
Recently, the structure of yeast eEF2 was determined by crystallography. The overall 
conformation of apo eEF2 is similar to that of its prokaryotic homologue EF-G in 




Fig. 1.4 Structure of apo form of yeast elongation factor eEF2. Domains of eEF2 are 
labeled. The domain G' is a large domain inserted in domain I，which is also often 
referred to as the G domain. Domain I is known to interact closely with the large 
ribosomal subunit, whereas domain II is in contact with the small ribosomal subunit 
[Andersen et al, 2003] 
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1.5 Objective and strategy of studying the interaction among 
trichosanthin，P-proteins and eukaryotic elongation factor 2 
Ricin A chain can depurinate both adenine 4324 of 28S rRNA in intact rat ribosome 
and naked 28S rRNA but with a different kcat value. The rRNA in the ribosome is 
depurinated by ricin with a kcat nearly 10^  -fold greater than that measured using the 
naked 28S rRNA [Endo and Tsurugi, 1987]. Besides, ricin A chain has no effect on 
23S rRNA in Escherichia coli ribosomes. The N-glycosidase activity on naked 23S 
rRNA of E. coli shows that ribosomal proteins may play an important role in 
ribosome-inactivating activity of RIP. 
Recently, TCS is found to interact with ribosomal proteins PO and PI by yeast-two 
hybrid system [Chan et al, 2001] and P2 by in vitro binding assay [unpublished data]. 
The interaction between TCS and P-proteins may be important in 
ribosome-inactivating activity of TCS. Since, binding of P-proteins is crucial for the 
eEF2 GTPase activity for protein synthesis, the interaction of TCS and P-proteins 
may hinder the binding of eEF2 to ribosome for protein synthesis. 
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Prior to studying the interactions among TCS, P-proteins and eEF2, our group has 
cloned cDNA of human PO, PI and P2 into non-fusion vector and overexpressed the 
proteins using E. coli system. P2 can be expressed in soluble form and purified in 
high yield while PO expressed in inclusion body and PI formed soluble aggregate 
[Lee K.M., unpublished data]. Besides, the three dimensional structure of P2 is being 
determined using NMR technique by our group, the structural data helps to elucidate 
the interactions among the proteins. Therefore P2 was employed as a model for TCS 
and P-protein interaction. 
In the present study, site-directed mutagenesis was employed to mutate the suspected 
TCS-P2 interaction sites discovered by NMR study. The mutated proteins were 
overexpressed and purified. The biological activities of TCS variants and their 
interaction with P2 were assayed to investigate the correlation between P-protein 
binding and TCS biological activity. 
Furthermore, to investigate if TCS competes with eEF2 for binding with P2, the 
regions on P2 that interact with TCS and eEF2 were mapped by systematic deletion. 
In vitro binding assay was used to screen the interaction between the P2 truncation 
mutants and TCS or eEF2 respectively. 
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The ultimate goal of this work is to understand the correlation of TCS ribosome 
inactivating activity and its interaction with P-proteins. Then, it can be served as a 
model to further understand the ribosome inactivating activity of other RIPs. Besides, 
mapping the region of P2 which interact with eEF2 in the course will help to 
understand the structure-function of the eukaryotic ribosomal stalk proteins. 
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Chapter 2 Materials and Methods 
2.1 General Techniques 
2.1.1 Preparation and transformation of Escherichia coli competent cells 
The following method was adopted from Sambrook et al (1989) with certain 
modifications. Escherichia coli strain DH5a or BL21(DE3)pLysS was streaked from 
a frozen stock onto the surface of an LB agar for DH5a or LB agar plate with 25 
|ag/ml chloramphenicol for BL21(DE3)pLysS and incubated at 37°C for 14 to 16 
hours. Single colony from the plate was inoculated to 5 ml of LB medium at 37°C at 
250 rpm until OD600 reached 0.3 to 0.4 unit (about 3 hours). The culture was added to 
100 ml LB medium and continued shaking at 37°C until ODeoo reached 0.4 to 0.5 unit 
(about 2 hours). The culture was then chilled on ice for 5 minutes and then 
centrifuged at 5000 rpm (Beckman rotor JLA 16.250) for 10 minutes at 4°C. The 
bacterial pellet was resuspended in 40 ml RFl (section 2.11.1) and then kept on ice 
for 5 minutes. The bacterial suspension was then centrifuged again at 5000 rpm for 10 
minutes at 4°C. The bacterial pellet was then resuspended in 4 ml RF2 (section 2.11.1) 
and kept on ice for 15 minutes. The cells were then aliquoted into 1.5 ml microfuge 
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tubes in 100 per tube and frozen in liquid nitrogen. The cells were then stored 
at -70°C until use. 
Just before use, an aliquot of 100 of competent cells was quickly thawed on hand. 
Appropriate quantity of DNA was added to the cells and mix. The cell was then left 
on ice for 30 minutes. The tube was transferred to a 42°C water bath or a pre-warmed 
thermocycler for 2 minutes without shaking. The tube was then incubated on ice for 
10 minutes. For ligation product, 400 of LB was added to the cells and incubated at 
37°C at 250 rpm for 45 minutes. The cells were then pelleted by centrifugation at 
12,000 rpm at bench-top centrifuge at room temperature for 2 minutes and 
resuspended in 100 |il of LB which was then spread to a 90-mm LB agar plate 
containing appropriate antibiotic. For plasmid DNA, the cells were diluted with 400 
of LB and 100 i^l of bacterial cells were spread to a 90-mm LB agar plate 
containing appropriate antibiotic. 
2.1.2 Minipreparation of plasmid DNA using Wizard Plus SV Minipreps 
DNA purification kit from Promega 
J , 
Procedures were essentially those recommended by the manufacturer. A single 
bacterial colony on an LB agar plate with appropriate antibiotic was inoculated into 5 . 
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ml of LB medium containing the appropriate antibiotic in a capped sterile 25 ml bottle. 
The culture was incubated at 37°C at 250 rpm for 14 to 16 hours. Bacterial pellet was 
collected by centrifugation at 13,000 rpm for 2 minutes in a microfuge tube. The 
pellet was resuspended in 250 [i\ of cell resuspension solution and then mixed with 
250 [i\ of cell lysis solution by inversion. Ten microlitre of alkaline protease supplied 
by manufacturer was added and incubated at room temperature for 5 minutes or less. 
350 fil of neutralization solution was then added and mixed by inversion, t h e mixture 
was then centrifuged at 13,000 rpm for 15 minutes. The supernatant was then 
removed carefully and added to the DNA-binding cartridge with waste collection tube 
connected at the bottom. After centrifugation at -5000 g for 1 minute, 750 |j,l of 
column wash solution was added and re-centrifuged. Washing was repeated with 250 
pi of column wash solution. After two washing steps, 100 |il of sterile water or 
elution solution supplied by the manufacturer was added to the column with a clean 
1.5-ml microfuge tube attached at the bottom. The assembly was then centrifuged at 
13,000 rpm for 1 minute and the plasmid collected at the microfuge tube was stored at 
-20°C. . 
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2.1.3 Agarose gel electrophoresis of DNA 
The agarose gels were prepared with 1.0 to 1.5% (w/v) agarose dissolved in Ix TAE 
buffer containing 0.5 |ig/ml ethidium bromide. The volumes of DNA samples were 
adjusted to 10，20 or 50 |J.1 with water or the running buffer with addition of 6x 
loading buffer (section 2.11.2.) to a final concentration of Ix. After loading the 
samples into the wells of the gel, electrophoresis was performed at constant voltage of 
90 to 125 V (10 to 14 V/cm) in a gel tank containing appropriate Ix TAE buffer. 
When electrophoresis was finished, DNA was visualized on a UVP model M-20 
transilluminator and, if necessary, photographed by Imago compact imaging system. 
2.1.4 Purification of DNA from agarose gel using Wizard SV Gel and PCR 
Glean-Up System from Promega 
Procedures were essentially those recommended by the manufacturer. After 
electrophoresis, the agarose gel containing separated DNA was visualized on the UVP 
y v transilluminator. The DNA band from gel was excised and placed in a 1.5ml 
microcentrifuge tube. The weight of the gel slice was measured and 10|il Membrane 
Binding Solution per lOmg of gel slice was added. The gel slice was vortexed and 
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incubated at 50-65°C until it was completely dissolved. The SV minicolumn provided 
by manufacturer was inserted into the collection tube and the dissolved gel mixture 
was transferred to the minicolumn assembly and incubated at room temperature for 1 
minute. After centrifuging at 13,200 rpm at bench-top centrifuge for 1 minute, the 
flow-through was discarded and the minicolumn was reinserted into the collection 
tube. 700|il membrane wash solution was added to the assembly and centrifuged at 
13,200 rpm for 1 minute. The flow-through was discarded and the assembly was 
re-centrifuged at 13,200 rpm for 5 minutes with 500fil membrane wash solution added. 
Then the minicolumn was transferred to a clean 1.5ml microcentrifuge tube. The 
minicolumn was incubated with SO i^l sterile water or nuclease-free water supplied by 
the manufacturer. The assembly was centrifuged at 13,200 rpm and the eluted DNA 
was stored at -20°C. 
2.1.5 Polymerase Chain Reaction (PGR) 
2.1.5.1 Basic Protocol 
PGR was carried out to introduce mutations and/or restriction sites to the cloned gene. 
Reactions were performed in a 50 |al-scale routinely in ABI PGR System 2400 or ABI 
PGR System 2700 in 500 ^il-microfuge tubes without application of top mineral oil 
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where lid heating is available. The reaction mix was prepared in the sequence 
depicted as follows unless otherwise specified: 
Sterile dFbO (41 - X ) 
1 Ox reaction buffer 5 |LX1 
dNTP (10 mM, 2.5 mM each of 1 )il 
dATP, dTTP, dGTP and dCTP) 
Forward primer (O.lnmole/fil) 1 
Reverse primer (0.1nmole/|al) 1 [i\ 
Template DNA X 
DNA polymerase (3 U/|j,l) 1 \i\ 
Total “ “ 5 M 
Reaction programs and primers differed in different applications were detailed in the 
following sections. After reaction, the mixture was analyzed by agarose gel 
electrophoresis or stored at 4°C for short period of time or -20°C for long-time 
storage. 
2.1.5.2 Generation of P2 truncation mutants 
PGR was carried out by using Pfu DNA polymerase (Promega) due to its high fidelity. 
Site-directed mutagenesis was achieved by using specially designed mutagenic 
primers (the following table) of which the sequences are listed in section 2.12. 
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Name Template Forward primer Reverse primer 
P2C1 pET8C-P2 P2-iVcoI-NF VlCX-BamHl-CK~ 
P2C2 pET8C-P2 P2-"coI-NF VlCl-BamHl-CK 
" P ^ pET8C-P2 P 2 - 勤 I-NF P2C3-B 續 / / I - C R ^ 
P2C4 pET8C-P2 P2-旋 oI-NF P2C4-5awM-CR 
"P2C5 pET8C-P2 P 2 - 勤 I-NF P 2 C 5 - B a w M - C R ^ 
P2C17 pET8C-P2 P2-A^coI-NF P2C17-5amM-CR 
Reactions were carried out using the following scheme: 
Cycle Denaturation Annealing Extension 
1st cycle 95°C, 8 minutes 55°C, 1 minute 72°C, 1 minute 
2nd to 29th cycle 95�C，1 minute 55°C, 1 minute 72°C, 1 minute 
30th cycle 95°C, 1 minute 55°C, 1 minute 72°C, 1 minute 
2.1.5.3 Generation of TCS mutants 
TCS mutants I121A, K177AL180A, L180A were generated by two PGR reactions. 
The first PGR reaction generated the N-terminal and C-terminal fragments separately 
using the general PGR protocol with the following primer combination. 
39 
First PGR Template Forward primer Reverse primer 
TCS-I121A-N pET8C-TCSTCS-NF TCS-I121A-R 
TCS-I121A-C pET8C-TCSTCS-I121A-F TCS-CR 
T C S - K 1 7 7 A L 1 8 0 A - N P E T 8 C - T C S ~ ~ T C S - N F T C S - K 1 7 7 A L 1 8 0 A - R 
T C S - K 1 7 7 A L 1 8 0 A - C P E T 8 C - T C S T C S - K 1 7 7 A L 1 8 0 A - F T C S - C R 
TCS-L180A-N pET8C-TCS~~TCS-NF TCS-L180A-R 
TCS-L180A-C pET8C-TCSTCS-L180A-F TCS-CR 
TCS-N236A-N pET8C-TCSTCS-NF TCS-N236A-R 
The PGR products of the two reactions were analyzed and purified by 1.5% agarose 
gel in Ix TAE buffer. The PCR products were recovered from the gel by Promega 
Wizard SV Gel and PGR Clean-Up System. The recovered PCR products were used 
as templates in the second PCR. 
For the second PCR reaction, the N- and C-terminal fragments which contain 
overlapping region were used as the template to obtain a full length TCS mutant 
sequence using primers TCS-NF and TCS-CR. 
Second PCR Template Forward Reverse primer 
primer 
P ^ products ^ TCS-NF TCS-CR 
'' N-terminal fragment and 
C-terminal fragment � 
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The PGR product was then analyzed and purified by agarose gel electrophoresis and 
Progenia Wizard SV Gel and PGR Clean-Up System. The recovered PGR products 
were cleaved by Ncol and BamUl and ligated to pET8c. 
2.1.6 Restriction digestion of DNA 
Restriction digestion of DNA was carried out routinely in a volume of 20 in an 
appropriate buffer as suggested by the supplier. The reaction was performed with 10 
U or 20 U of each enzyme at 37°C for 2 hours. After digestion, the reaction mixture 
was analyzed by agarose gel electrophoresis. If desired, the cleaved DNA was 
recovered from the gel by Progenia Wizard SV Gel and PGR Clean-Up System for 
ligation. 
2.1.7 Ligation of DNA fragments 
Ligation reaction was performed in a volume of 20 [i\ at 16°C for 16 hours or more 
routinely. T4 DNA ligase (40 U/^il) (New England BioLabs Inc.) was used with 
reaction buffer provided by manufacturer. Reaction mixture was prepared in the order 
depicted as follows: 
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Sterile dUjO ( 1 7 - X - Y ) 
1 Ox ligase buffer 2 
Linearized vector X fil 
DNA insert Y 
T4 DNA ligase (40 U/|al) 1 |al 
Total 207n 
After ligation, the reaction product was added to freshly thawed DH5a competent 
cells for transformation. 
2.1.8 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
All SDS-polyacrylamide gels were run using the Mini-PROTEAN III electrophoresis 
cell (BioRad). One short glass plate and one spacer (0.75mm) glass plate were 
cleaned 70% ethanol by wiping with lint-free tissue paper and were assembled into 
the casting frame according to manufacturer's instructions. The separating gel 
solution of different acrylamide concentration was prepared as follows: 
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Resolving gel (for two mini gels) 10% 12.5% 15% 
dHiO 3.7 ml 2.5 ml 1.9 ml 
4x resolving gel buffer (pH 8.8) 2.0 ml 2.0 ml 2.0 ml 
30% acrylamide (29% acrylamide, -- 3.3 ml 4 ml 
1% bis-acrylamide) 
40% acrylamide(38% acrylamide, 2% 2.0ml - --
bis-acrylamide) 
10% ammonium persulfate 100 |li1 100 100 i^l 
TEMED 4^1 作1 4^1 
About 3.2ml of the separating gel solution was transferred into the gap between the 
glass plates by a 1 ml pipette. 200 |j,l of isopropanol was added to the top of the gel to 
keep the gel solution out of atmospheric oxygen and to remove bubbles on the 
solution surface. After the solution polymerized completely in about 15 minutes, the 
isopropanol was poured off and the gel surface was washed extensively with dHzO. 
The gel surface was then dried by placing a piece of Whatman 3-mm filter paper near 
the gel surface. Stacking gel solution of 5% acrylamide was prepared as follows: 
J 
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Stacking gel (for two mini gels) 5 % 
dUiO 2lni 
4x stacking gel buffer (pH 8.8) 0.89 ml 
30% acrylamide (29% acrylamide, 1% 0.6 ml 
bis-acrylamide) 
10% ammonium persulfate 50 \i\ 
TEMED 41^1 
Stacking gel solution was transferred to the top of the separating gel by a 1 ml pipette 
until the solution reached the margin of the outer glass plate. A comb of 0.75 mm 
thick with 10 or 15 well former was inserted into the gel between the glass plates. 
Appropriate volume of 2x SDS gel loading buffer was added to the sample. The 
samples were denatured by boiling for 10 minutes or heated in a thermocycler at 95°C 
for 10 minutes. The samples were centrifuged at 13,000 rpm at bench-top centrifuge 
for 2 minutes to pellet debris. After the stacking gel was set, the comb was removed 
and the wells were washed with dHzO. The gel cassette was then assembled into the 
electrophoresis cell. The upper (inner) chamber was filled with fresh 
SDS-electrophoresis buffer and the lower (outer) chamber with fresh or re-used 
SDS-electrophoresis .buffer. Electrophoresis was performed at 35 to 60 mA per gel 
until the bromophenol blue dye reached the bottom of the running gel. The gel was 
44 
then removed from the electrophoresis cell and stained with Coomassie Brilliant blue 
R250 or equilibrated in transfer buffer for Western blotting. 
2.1.9 Staining of protein in polyacrylamide gel 
After electrophoresis, the gel was immersed in about 30 ml of staining solution 
containing 0.15% Coomassie Brilliant Blue R250, 30 % (v/v) ethanol, 10 % (v/v) 
acetic acid for 1 hour or more at room temperature or 70°C for 30 minutes with 
continuous shaking. The gel was then destained with destaining solution containing 
25 % (v/v) ethanol, 8 % (v/v) acetic acid with a piece of paper towel at room 
temperature or at 70�C until destaining was completed. Alternatively, the stained gel 
was destained in destaining solution in a microwave oven at high power for 1 to 2 
minutes followed by shaking at 55�C for 1 hour. After destaining, the gel was 
equilibrated in dHsO and dried by wrapping in glassy paper over a glass plate. 
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2.2 Expression and purification of recombinant proteins 
2.2.1 Bacterial culture, harvesting and lysis 
Gene was ligated to pET8c or pRMBP at correct reading frame and transformed to E. 
coli BL21 (DE3) pLysS. Ten colonies were inoculated to 10 to 20 ml LB medium 
containing 100 |Lig/ml ampicillin and 100 |Lig/ml chloramphenicol (LBAC medium) 
and incubated at 37°C at 250 rpm for 2 to 3 hours. The starter culture was then 
inoculated to 1 liter of fresh LB AC medium at 1% (v/v) inoculation. The broth was 
allowed to grow at 37�C at 250 rpm until ODeoo reached 0.4 to 0.8 unit (usually takes 
about 3 hours). 0.4M IPTG was then added to final concentration of 0.4mM for 
induction. The broth was allowed to grow for 4 more hours or overnight and then 
harvested by centrifugation at 6,000 rpm (Beckman rotor, JLA 16.25) at 4 � C for 10 
minutes. The bacterial pellet was then resuspended in 30 ml per liter culture of 20 mM 
phosphate buffer (PB), pH 6.5 (section 2.11.4) or 20mM Tris buffer, pH 7.8 or 8.5 
containing 0.5 mM phenylmethysulfonyl fluoride (PMSF) and 0.1% (v/v) 
p-mercaptoethanol. The suspension was sonicated for 6 cycles of 1 minute on ice (4 
seconds pulse, 80% output). The lysate was first aliquot for analysis by SDS-PAGE 
and then centrifuged at 15,000 rpm (Beckman rotor, JA 30.5) for 30 minutes at 4°C. 
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2.2.2 Purification of recombinant TCS and mutants 
TCS or mutant genes were cloned into the vector pET8C and overexpressed in E. coli 
strain BL21(DE3) pLysS. The culture cells were harvested and lysed by sonication. 
The supernatant containing TCS or mutants was collected for purification. Cation 
exchange chromatography was carried out using Amersham Bioscience AKTA prime 
system with an C column 16/20 of CM-Sepharose Fast Flow (Amersham Biosciences). 
Flow rate was maintained at 5 ml/min and protein content of the eluent was monitored 
online by OD280 with an UV detector. Before each run, the column was washed with 
5x volumes (about 180 ml) of 1 M NaCl in 20 mM PB, pH 6.5 (section 2.11.4) and 
then equilibrated in 5x volumes of 20 mM PB, pH 6.5. The supernatant of lysate 
(about 30 ml for 1 liter culture) was applied to the column and washed until the OD280 
signal returned to the baseline. A 500 ml linear gradient of 0 to 0.5 M NaCl in 20 mM 
PB, pH 6.5 was applied at a flow rate of 3 ml/ min and fractions were collected at 2 
minutes per tube (6ml/fraction). After the gradient, the column was washed with 1 M 
NaCl in 20 mM PB, pH 6.5 and then 20% ethanol for storage of column. 
J _ 
According to the high of the peak shown on the chart recorder, 5 to 10 i^l of peak 
fractions were analyzed on a SDS-PAGE. After SDS-PAGE analysis, the appropriate 
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peak fractions were pooled or further purified by cation exchange chromatography 
with 5 ml Hi-Trap™ SP Sepharose column. The pooled fractions were dialyzed 
against 20 mM PB，pH 6.5 extensively at 4 � C and loaded to a column equilibrated 
with 20mM PB, pH 6.5. A 300ml linear gradient of 0 to 0.3M NaCl in 20 mM PB, pH 
6.5 was applied at a flow rate of 3 ml/ min and fractions were collected at 2 minutes 
per tube (6ml/fraction). After SDS-PAGE analysis, the fractions with pure protein 
were concentrated by Amicon with membrane of molecular cut-off of 5kDa 
(Millipore). Protein concentration was determined by OD280 measurement and then 
stored at -20°C. 
2.2.3 Purification of acidic ribosomal protein P2 and mutants 
P2 or mutant genes were cloned into the vector pET8C and overexpressed in E. coli 
strain BL21(DE3) pLysS. The culture cells were harvested and lysed by sonication. 
The supernatant containing P2 or mutants was collected for purification. Anion 
exchange chromatography was carried out using Amersham Bioscience AKTA prime 
J system with an C column 16/20 of DEAE-Sepharose Fast Flow (Amersham 
Biosciences). Flow rate was maintained at 5 ml/min and protein content of the eluent 
was monitored online by OD280 with an UV detector. Before each run, the column 
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was washed with 5x volumes (about 180 ml) of 1 M NaCl in 20 mM Tris, pH 7.8 or 
8.5 and then equilibrated in 5x volumes of 20 mM Tris, pH 7.8 or 8.5. The 
supernatant of lysate (about 30 ml for 1 liter culture) was applied to the column and 
washed until the OD280 signal returned to the baseline. A 500 ml linear gradient of 0 
to 0.5 M NaCl in 20 mM PB, pH 6.5 was applied at a flow rate of 3 ml/ min and 
fractions were collected at 2 minutes per tube (6ml/fraction). After the gradient, the 
column was washed with 1 M NaCl in 20 mM PB, pH 6.5 and then 20% ethanol for 
storage of column. 
After SDS-PAGE analysis, the fractions containing P2 were pooled and further 
purified by size exclusion chromatography. The fractions pooled were concentrated to 
volume 5 to 10 ml and loaded to Superdex'^'^ 200 column in 20mM Tris, 0.2M NaCl, 
pH 7.8 or 8.5 at flow rate 2.5ml/min and fractions were collected at 2 minutes per 
tube (5 ml /fraction) at appropriate elution volume. The fractions containing P2 or 
mutants were pooled and dialyzed against 50-fold 20mM Tris, pH 7.8 or 8.5 at 4°C 
overnight. The dialyzed sample was then purified by Hi-Trap丁M Q HP or Hi-Trap^'^ 
ANX HP column with a 500ml linear gradient 0-0.5M NaCl in 20mM Tris, pH 7.8 or 
8.5 at a flow rate 3ml/min and fractionated at 6ml/ fraction. The purified P2 or 
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mutants was then concentrated using Amicon with membrane of molecular cut-off at 
5kDa and stored at -20T. 
2.2.4 Purification of MBP-fusion proteins 
P2 C-terminal peptide genes were cloned into the vector pRMBP and overexpressed 
in E. coli strain BL21(DE3) pLysS. The culture cells were harvested and lysed by 
sonication. The supernatant containing MBP-fusion protein was collected for 
purification using metal chelating sepharose fast flow column (Amersham 
Biosciences). Copper (II) chloride (O.IM) was first used to charge up the column. The 
filtered sample was loaded to the copper column equilibrated with 20mM PB, IM 
NaCl, pH 7.4. The fusion protein was then eluted with 500ml linear gradient of IM 
NaCl- to IM NH4CI in 20mM PB, pH 7.4 at 3ml per minute and 6 ml per fraction. 
After SDS-PAGE analysis, the fractions containing fusion protein were pooled and 
further purified by Hi-Trap Q™ column when necessary. 
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2.3 Purification of eEF2 from rat livers 
All the homogenizing and centrifugation procedures were done at 0 - 4°C. Livers 
from adult Sprague-Dawley rats were homogenized with 0.5mM PMSF in 
homogenizing buffer (section 2.11.5) (2-2.5ml/g of tissue) using an electronics tissue 
tearer. The lysate was centrifuged at 15,000 rpm for 30 minutes (Beckman rotor, JA 
30.5) to remove the cell debris. The supernatant was then precipitated with 
ammonium sulfate at 40-60 % saturation. Ammonium sulfate precipitant was 
collected by 10,000 rpm, 30 minutes (Beckman rotor JLA 16.25). The pellet collected 
was resuspended with Buffer A (section 2.11.5) with minimal volume and dialyzed 
against more than 25-fold Buffer A at 4�C overnight. The dialyzed sample was spun at 
15,000 rpm, 30 minutes (Beckman rotor JA 30.5) to remove some unwanted protein 
"precipitate. The supernatant was filtered though 0.22|^m filter (Millipore) and loaded 
to 100 ml DEAE Sepharose (Amersham Biosciences) equilibrated with Buffer A 
packed in Biorad Econo column (2.5 cm x 30 cm). The column was washed with two 
beds of Buffer A and the flow-through was collected. Proteins bound to DEAE 
column was step-eluted with Buffer A with 150mM KCl. Around 75ml of yellow 
fraction was collected. 
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The fraction collected from DEAE chromatography was then directly loaded to 5ml 
Heparii/M Hi-Trap column (Amersham Biosciences) equilibrated with Buffer A. The 
column was washed with Buffer A until OD280 signal reached the baseline, A 200ml 
linear 50- 500 mM KCl gradient was applied at flow rate 3 ml/ minute and fraction 
was collected at 6 ml per tube. After gradient, the heparin column was washed with 
Buffer A with 500mM KCl and stored at 4°C with 20% ethanol. 
After Western blotting analysis, the fractions containing eEF2 were pooled and 
concentrated to about 5 ml using Amicon with molecular cut-off of 30 kDa 
(Millipore). The concentrated sample was further purified by gel filtration 
chromatography using Superdex^'^ 200 column equilibrated in Buffer A at flow rate 
2.5ml per minute and fractionated at 3 or 5ml per tube. The fractions containing eEF2 
"after SDS-PAGE analysis were pooled and subject to another ion exchange 
chromatography. 
AKTA explorer system and Mono Q HR 16/10 column (8 ml gel volume) were 
employed. Fraction pooled was loaded to the column equilibrated with Buffer A. The 
unbound proteins were washed with two bed volumes of Buffer A. A 25 bed linear 50-
500mM KCl gradient of Buffer A was applied at flow rate 2 ml/ minute and fractions 
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were collected at 4 ml per tube. Finally the column was washed with 2M NaCl and 
stored in 20% ethanol at 4°C. The purified eEF2 was concentrated using Amicon and 
stored in Buffer A at -20°C. 
2.4 In vitro binding assay by NHS-activated Sepharose resin 
2.4.1 Coupling of protein sample to NHS-activated Sepharose resin 
1 ml of coupling protein (TCS or P2) at about 10 mg/ml was dialyzed in 500ml of 
coupling buffer (section 2.11.8) overnight at 4 � C and protein concentration 
determined by spectrophotometric quantification. About 1 ml of NHS-activated 
„ Sepharose resin (Amersham Bioseciences) was packed with 100% isopropanol in an 
empty NAP-10 column. The packed resin was washed with 3 x 2ml (2 beds resin 
volume) ice-cold ImM HCl by gravity. Then i ml dialyzed protein sample was loaded 
to the column. The column was sealed with tap at the bottom and stood at room 
temperature for 15 to 30 minutes. The column was then washed with 3 x 2 ml wash 
coupling buffer A (section 2.11.8). The first 3-ml wash was collected for protein 
concentration determination. The column was then washed with 3x 2 ml of coupling 
wash buffer B (section 2.11.8) and then wash buffer A. The column was stood in 
53 
wash buffer A at room temperature for 15 to 30 minutes. The column was washed 
with 3x 2 ml wash buffer B again and then wash buffer A. Final wash with 3x 2 ml of 
wash buffer B and then wash column with 2x 2 ml of storage buffer (section 2.11.8). 
The column was stored with 3 beds storage buffer at 4°C. 
2.4.2 In vitro binding of protein sample to coupled NHS-activated resin 
Protein preparation was dialyzed against appropriate binding buffer at 4°C overnight. 
200|j.l of TCS or P2 coupled NHS-activated resin was packed into 1ml Biorad Econo 
column and equilibrated with 5 ml binding buffer (section 2.11.9). 200|LI1 dialyzed 
protein sample was loaded to a column with the flow-through fraction collected. The 
column was incubated at room temperature for 15 to 30 minutes and first four 500|uil 
“washing fractions by binding buffer were collected. The column was then washed 
with 5 ml binding buffer and the last 500|LI1 washing fraction was also collected. 
Adsorbed proteins were eluted by elution buffer with IM NaCl (section 2.11.9). The 
first four 200|li1 elution fractions were collected and then the column was washed with 
5 ml elution buffer. The last 200}il elution fraction was collected and all the fractions 
were analyzed by SDS-PAGE. The column was washed with 5 ml storage buffer and 
stored in 1 ml storage buffer at 4°C. 
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2.5 Ribosome-inactivating activity assay using rabbit 
reticulocyte lysate in vitro translation system 
Untreated rabbit reticulocyte lysate (in-house production) was used to carry out in 
vitro translation. The method was modified from that of Yeung et al (1988). TCS 
concentration range was 10"^  - 10^  nM. Master mix and working lysate were prepared 
as follows: 
Master Mix: 
7.5 samples 22.5 samples 
Creatine phosphate (0.8 M) 4 |il 12^1 
KCl/MgCl2 (2 M/10 mM) 10 i^l 30 |il 
dHzO 23.5 1^1 70.5 |il 
^H-leucine (5 mCi/ml) 7.5 i^l 22.5 fil 
Working Lysate: 
7.5 samples 22.5 samples 
Rabbit reticulocyte lysate 100 |il 300 |al 
dHiO 100 III 300 
Creatine kinase (5 mg/ml) 2 |LI1 6 \i\ 
Hemin (1 mg/ml) 10|al 30 
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Four microliter of master mix and 4 jul of sample or BSA (0.5 mg/ml) were added to 
30 fil of working lysate to initiate translation. The mixture was incubated at 30°C for 
30 minutes in an incubator. Two controls were done. In control 1, dHzO was used 
instead of working lysate. In control 2, BSA was added instead of sample. Three 
aliquots of 7 were taken from each tube to a 10 x 130 mm-test tube. Freshly 
prepared 0.5 ml NaOH/HiOi (1 M/10%) was added and incubated at 37°C for 40 
minutes or at room temperature for 2 hours. 1 ml of ice-cold 25% trichloroacetic acid 
(TCA) was added to each tube to precipitate the proteins. The precipitates were 
collected by filtration through 25 mm-circular GF/B filter (Whatman) under suction. 
The filters were washed with two times 8% TCA and two times with absolute or 95% 
ethanol. After the washed filters were dried, the filters were transferred to scintillation 
vials into which 3 ml scintillation fluid (Hisafe 2 liquid scintillation cocktail, 
Perkinelmer) was added. Radioactivity was measured by liquid scintillation counting 
using a Beckman LS 6500 liquid scintillation counter. 
,1 
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2.6 Circular dichroism (CD) spectrometry 
Secondary structures of P2 and mutants were studied by CD spectrometry. CD spectra 
in the peptide region (190 to 260 nm) were measured by a Jasco J-810 
spectropolarimeter using a quartz cuvette of 0.1 cm path length at 25°C. The samples 
were adjusted to 50 fiM in 10 mM sodium phosphate buffer, pH 7.4 for data 
acquisition. Each protein was scanned from 190 to 260 nm three times and the spectra 
were averaged, subtracted from buffer blank spectrum and expressed as molar 
ellipticity. Deconvolution of CD spectra to alpha helix, beta sheet, turn and other 
conformations was done by the self-consistent method (computer program Selcon) 
[Sreerama and Woody, 1993]. 
2.7 Isothermal titration calorimetry (ITC) experiment 
The experiment was carried out using Nano ITC series III (N-ITC) model 5300 
(Calorimetry Sciences Corp.). Purified TCS and P2 or P2 mutants in appropriate 
concentration were dialyzed against 20mM Tris, pH 7.8 overnight at 4�C. Both TCS 
and P2 were dialyzed in the same buffer to minimize the heat change due to different 
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buffer system of the samples. The dialyzed protein samples were then degassed by 
vacuum pump for more than 90 minutes to ensure any tiny gas bubble in the sample 
was removed completely. 
The sample cell of the N-ITC system was washed with the degassed 20mM Tris, pH 
7.8 for several times. About 1.5 ml degassed TCS sample was injected into the sample 
cell. The degassed P2 sample was placed in the injection syringe which was 
assembled to the instrument. The experiment started after equilibrating for 10000 
seconds. Twenty injections of 5[d P2 were applied into the sample cell with 500 
seconds interval. Results were analyzed using Titration Bind Works Version 3.0.78. 
(Calorimetry Sciences Corp.). 
2.8 . Surface plasmon resonance (SPR) experiment 
2.8.1 Immobilization of P2 onto aminosilane cuvette 
Surface plasmon resonance experiment was carried out using lAsys manual Biosenor 
system (Affinity Sensor, Thermo Instrument System Inc.). Purified P2 was 
immobilized on an aminosilane cuvette (Affinity Sensor, Thermo Instrument System 
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Inc.) via polymerized glutaraldehyde (G5882, Sigma) according to the manufacturer's 
protocol. Polymerized glutaraldehyde was prepared by taking 5ml of 5% (v/v) 
glutaraldehyde and adding 500)J,1 of 0.1 M NaOH. The mixture was left for 30 minutes 
to polymerize and 500|^1 of O.IM HCl was added for neutralization. The final 
concentration of polymerized glutaraldehyde was 4.2% (v/v). 
The aminosilane cuvette was placed in the instrument and washed with the 
immobilization buffer (section 2.11.10) and left for 10 minutes. The cuvette was 
washed again with immobilization buffer to obtain the buffer baseline for 7 minutes. 
The 4.2% (v/v) polymerized glutaraldehyde (200|^1) was added to activate the amino 
groups on the biosensor surface for 30 minutes. Then the cuvette was washed with 
immobilization buffer for 5 minutes to remove the activation mixture. P2 in the 
”immobilization buffer was added to the cuvette and left for 30 minutes for coupling 
reaction. The cuvette was washed with immobilization buffer for 5 minutes. Coupling 
efficiency was calculated by the response signal. The unreacted polymerized 
glutaraldehyde on the cuvette was blocked by blocking agent (2.11.10) for 5 to 10 
minutes to minimize non-specific binding. Finally, the cuvette was washed with 
immobilization buffer and it was ready for binding experiment. 
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2.8.2 Interaction between eEF2 and immobilized P2 
Different concentrations of eEF2 in the binding buffer (section 2.11.10) were prepared. 
The aminosilane cuvette coupled with P2 was washed with binding buffer and lOOjil 
binding buffer was added to obtain the buffer baseline for 5 minutes. Twenty-five 
micro-litre of 5x concentrated eEF2 was applied to the lOOjil binding buffer for 
association with immobilized P2 for 5 minutes. Then the reaction mixture was 
replaced with lOO i^l binding buffer for dissociation for 5 minutes. The cuvette was 
regenerated by washing with regeneration buffer (section 2.11.10) for three times and 
left for 1 to 2 minutes. The cuvette was washed with 200|il binding buffer three times 
and the above procedure could be repeated for another concentration of eEF2. After 
the experiment, the buffer in the cuvette was removed and the cuvette was wrapped 
’ with parafilm and stored at 4�C to prevent drying. Results were analyzed using lAsys 
FASTfit version 2.01 (Affinity Sensor, Thermo Instrument System Inc.). 
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2.9 Preparation of Anti-P antibody 
The C-terminal regions of PO, PI and P2 were highly conserved. Therefore the 
C-terminal 17 amino acid sequence was selected to raise antibody against P-proteins. 
The 17-mer N-terminal acetylated peptide (KEESEESDD DMGFGLFD) was 
purchased from Peptron Inc. One milligram of peptide was used to inject to rabbit to 
raise antibody. The injection and blood collection procedure were carried out by a 
technician in the Department of Biochemistry The blood collected was left in room 
temperature overnight for coagulation and centrifuged at 3500 rpm (rotor) at 4°C for 
20 minutes twice to remove the blood clot. The supernatant serum was collected was 
stored at -80� . Five milli-liters of second bleed serum collected were diluted with 45 
“ m l 20mM PB, pH 7.0. The diluted serum was loaded to 5 ml Hi-Trap"™ Protein G 
column (Amersham Biosciences) equilibrated with 20mM PB, pH 7.0. The column 
was washed until the OD280 signal returned to baseline. Then the IgG were step eluted 
with O.IM glycine-HCl, pH 2.7 at flow rate 5 ml/ minute and 5ml per fraction. The 
fractions collected were neutralized with one-tenth volume of IM Tris, pH 7.2 and 
il 
tested by western blotting for the presence of anti-P antibody. The partially purified 
anti-P antibody was pooled, divided into lOO^l aliquot and stored at 4�C. 
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2.10 Western blotting of protein 
After electrophoresis, the stacking gel was discarded and the size of the resolving gel 
was measured (usually 5 x 8.5 cm) and equilibrated in transfer buffer (section 2.11.7) 
for 15 minutes or more. PVDF (Millipore) membrane and 6 pieces of Whatman 3-mm 
filter paper were cut to a size slightly larger than the gel ( 6 x 1 0 cm). The membrane 
was first rinsed briefly in analytic grade methanol to wet the membrane and then 
equilibrated in transfer buffer for 15 minutes or more. The 3 mm filter papers were 
stacked into two stacks of 3 pieces and wetted with transfer buffer. 
Electroblotting was carried out using a semi-dry electroblotter Trans-Blot Cell 
(BioRad). Three wetted filter papers were placed onto the cathode and rolled over 
with a. test-tube to expel air bubble. The equilibrated membrane was placed on top of 
the filter paper and a cut at the right top corner to mark the orientation and the surface 
presenting the protein bands. Then, the gel equilibrated with transfer buffer was 
placed on top of the membrane, followed by a stack of 3 wetted filter papers. The 
sandwich was then rolled over with a test-tube to expel bubble and excess buffer. 
Anode was then assembled to the blotter and constant voltage of 15 V was applied for 
60 to 100 minutes. 
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Electroblotted membrane was first blocked by 5% (w/v) non-fat milk and 1% BSA in 
TBST (section 2.11.7) at room temperature for 1 hour or 4°C overnight with 
continuous shaking. After washing with about 25ml TBST for 10 to 15 minutes three 
times, antibody or antiserum (primary antibody) of appropriate dilution with 3% 
non-fat milk in TBST was applied to the membrane and incubated at room 
temperature for 1 hour with continuous shaking. The membrane was then washed 
with 3 changes of TBST each of 10 to 15 minutes. Appropriate secondary antibody 
conjugated with horseradish peroxidase (HRP) was diluted in TBST in a 
concentration suggested by manufacturer with the membrane at room temperature for 
Ihour, followed by washing with 3 changes of TBST each of 10 to 15 minutes. 
- F o r RRP-conjugated secondary antibody, ECL (enhance chemiluminescence) kit 
(Amersham Pharmacia Biotech.) was used. 0.25 ml of solution A and 0.25 ml of 
solution B were mixed just prior to application and was applied to the membrane and 
incubated at room temperature for 1 minute. The solution mix was then stripped off 
by hanging over a paper towel and wrapped by a plastic wrap. The membrane was 
then exposed to a Kodak BioMax MS-1 film or Amersham Hyperfilm ECL at certain 
time intervals (usually 1 to 5 minutes). The exposed film was then developed with IX 
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Kodak X-ray developer for about 15 seconds until the bands were visualized and 
fixed with IX Kodak X-ray fixer for 3 minutes. The developed films were then rinsed 
with tap water for 3 minutes and air-dried. 
If necessary, the membrane was washed by dHaO and stained with Coomassie 
Brilliant blue R250 staining solution. After distaining with distaining solution, the 
membrane was washed with tap water and air-dried. ‘ 
2.11 Reagents and Buffers 
2.11.1 Reagents for competent cell preparation 
“RFl: 30 mM KAc, 100 mM R b C l � � 1 0 mM CaCh, 50 mM MnCh�15% glycerol. pH 
was adjusted to 5.8 by acetic acid. The solution should not be back titrated. Sterilized 
by filtration through 0.2 \xm filter. 
RF2: 10 mM MOPS, 75 mM CaCb, 10 mM RhCh, 15% glycerol. pH was adjusted to 
6.5 with KOH. Sterilized by filtration through 0.2 ]xm filter. 
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2.11.2 Nucleic acid electrophoresis buffers 
TAE (Tris-acetate-EDTA)�50x stock solution 
242 g/L Tris base 
57.1 ml/L glacial acetic acid 
37.2 g/LNa2EDTA.2H20 
Stored at room temperature 
6x agarose gel loading buffer 
0.25% (w/v) bromophenol blue 
40% (w/v) sucrose 
60 mM EDTA(pH8.0) 
Stored at 4°C. 
65 
2.11.3 Media for bacterial culture 
LB (Luria-Bertani) medium 
20 g/L LB Borth 




3 g/L KH2PO4 
6g/LNa2HP04 
5g/LNaCl 
10 g/L bacto-trypton 
Water was added to 990 ml, autoclave for 15 minutes. After cooling to less than 50°C, 
10 ml of sterile 40% glucose and 1 ml of sterile 1 M MgSO* were added. 
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Agar media 
Liquid media were prepared according to the recipes given above. 15 g ofbacto-agar 
was added to 1 liter liquid medium and autoclaved. 
2.11.4 Buffers for TCS purification 
20 mM phosphate buffer (PB), pH 6.8 
The buffer was prepared from 1 M PB stock solution. The pH of the diluted buffer is 
6.8 without adjustment. 
I M P B 
44.732 g/LNa2HP04 
53.43 g/LNaH2P04.2H20 
There was no need to adjust pH. pH equals to 6.8 if diluted to 20 to 50 mM. 
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2.11.5 Buffers for eEF2 purification 
Homogenizing Buffer 
20mM Tris, 0.27M sucrose, 30mM KCl, 5mM Mg(0Ac)2, ImM DTT, 
pH was adjusted to 7.6 with HCl. 
Buffer A 
20mM Tris, 10% glycerol, 50mM KCl, O.lmM EDTA，14mM P-mercaptoethanol, 
pH was adjusted to 7.6 with HCl and filtered before use. 
2.11.6 Reagents for SDS-PAGE 
SDS-electrophoresis buffer (lOx stock solution) 
30.2 g Tris base (0.125 M) 
144 g glycine (1.92 M) 
lOgSDS (0.5% (w/v)) 
dHiO was added to 1 L. There was no need to adjust pH. Buffer was stored at 4°C. 
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SDS-electrophoresis buffer (Ix working solution) 
The buffer was prepared from lOx stock solution. 
SDS-PAGE loading buffer (2x) 
100 mM Tris-HCl, pH 6.8，200 mM DTT，4% SDS, 0.2% bromophenol blue, 20% 
glycerol. The buffer was stored at -20°C for long-term storage or 4°C for short term. 
4x SDS resolving gel buffer, pH 8.8 
18.17 g/100 ml Tris base 
0.8 g/100 ml SDS or 4 ml/100 ml 10% SDS 
pH was adjusted to 8.8 with HCl. The buffer was stored at 4°C. 
4x SDS stacking gel buffer, pH 6.8 
6.06 g/100 ml Tris base 
0.8 g/100 ml SDS or 4 ml/100 ml 10% SDS 
pH was adjusted to 6.8 with HCl. The buffer was stored at 4°C. 
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staining solution 
30% (v/v) ethanol 
10% glacial acetic acid 
0.15% (w/v) Coomassie Brilliant Blue R250 
The solution could be reused many times until staining performance is no good. 
Destaining solution 
25% ethanol 
10% glacial acetic acid 
2.11.7 Reagents and buffers for Western blot 
Transfer buffer 
2.9 g/L glycine (39 mM) 
5.9 g/L Tris base (48 mM) 
0.37 g/L SDS (0.037%) 
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200 ml/L methanol (20%) 
There was no need to adjust pH. The buffer was stored at 4°C. 
TBS (lOx stock solution) 
24.2 g/L Tris base 
80 g/LNaCl 
pH was adjusted to 7.6 with HCl. The solution was stored at 4°C. 
TBS-T 
100 ml of lOx TBS was added to 900 ml ofdHiO. 1 ml ofTween 20® was added and 
stirred. The solution was stored at 4°C. 
Blocking solution 
5% (w/v) non-fat milk 
1%BSA 
The solution was dissolved in TBS-T. 
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2.11.8 Reagents and buffers for coupling sample proteins to NHS-activated 
Sepharose resin 
Coupling buffer: 0.2 M NaHCO]，0.5 M NaCl，pH 8.3 
Coupling wash buffer A: 0.5 M ethanolamine, 0.5 M NaCl, pH 8.3 
Coupling wash buffer B: o'l M NaOAc, 0.5 M NaCl, pH 4.0 
Storage buffer: 50 mM NaaHPO*，pH 7.0，0.1% NaN� 
2.11.9 Reagents and buffers for in vitro binding assay 
Binding buffers: 20mM Tris, lOmM NaCl, pH 8.0 
Elution buffer: 20mM Tris, IM NaCl, pH 8.0 
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storage buffer: 50 mM NazHPO*�pH 7.0, with 0.1% NaNa 
2.11.10 Reagents and Buffers for surface plasmon resonance 
Immobilization buffer: lOmM PB, pH 7.5 
Blocking agent: lOmM PB, 5mg/ml BSA, pH 7.5 
Binding Buffer: lOmM PB, pH 7.5 
Regeneration buffer: 20mM HCl 
2.12 Sequences of primers 
Primers of more than 15 nt were designed to ensure proper annealing to the template 
in PCR reaction. The primers were either "forward" (5’ to 3, with respect to the 
reading frame) or "reverse" (3，to 5, with respect to the reading frame). Restriction 
sites were underlined and start (ATG) or stop (TAG, TAA or TGA) codons were 
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bold-typed. 
Primers for TCS and its mutants 
TCS-NF, forward primer that annealed at the N-terminus of the coding sequence of 
mature TCS. A methionine (ATG) was added at 5' end for translation initiation. +Nco\ 
site. 
5, TGTGG CCATGG ATGT TAGCT TCCGT TTATC AGGTG 3' 
TCS-CR, reverse primer that annealed at C-terminus of the coding sequence of 
mature TCS. A stop codon (TAG) was added at 3’ end for termination of translation. 
+Bamm site. 
.5，CGCGGATCCT ATCGCC ATATT GTTTC TATTC AGCAG 3， 
TCS-I121A-F, forward primer that was used with TCS-CR to generate the C-terminal 
fragment (-390 nt) of 1121A TCS mutant in the first PGR of two-stepped sequential 
PGR. ATA of 1121 was changed to GCG (Ala). 
5’ CAA ACT GCT GCA GGC AAA GCG AGG GAA AAT ATT CCG CTT 3， 
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TCS-I121A-R, reverse primer that was used with TCS-NF to generate the N-terminal 
fragment (-380 nt) of 1121A TCS mutant in the first PGR of two-stepped sequential 
PGR. ATA of 1121 was changed to GCG (Ala). 
5'AAG CGG A AT ATT TTC CCT CGC TTT GCC TGC AGC AGT TTG 3' 
TCS-K177AL180A-F, forward primer that was used with TCS-CR to generate the 
C-terminal fragment (-230 nt) of K177AL180A TCS mutant in the first PGR of 
two-stepped sequential PGR. AAA of K177 was changed to GCG (Ala) and CTA of 
LI80 was changed to GCG (Ala). 
5 ‘ ATTGGG AAGCGTGTTGACGCGACCTTCGCGCC AAGTTTAGC AATTATA 3’ 
TCS-K177AL180A-R, reverse primer that was used with TCS-NF to generate the 
N-teraiinal fragment (-550 nt) of K177AL180A TCS mutant in the first PGR of 
two-stepped sequential PGR. AAA of K177 was changed to GCG (Ala) and CTA of 
LI80 was changed to GCG (Ala). 
5, TATAATTGCTAAACTTGGCGCGAAGGTCGCGTCAACACGCTTCCCAAT 3, 
TCS-L180A-F, forward primer that was used with TCS-CR to generate the 
C-terminal fragment (-220 nt) of L180A TCS mutant in the first PGR of two-stepped 
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sequential. CTA of LI 80 was changed to GCG (Ala). 
5' CGT GTT GAC AAA ACC TTC GCG CCAAGT TTA GCAATT ATA 3' 
TCS-L180A-R, reverse primer that was used with TCS-NF to generate the 
N-terminal fragment ( � 5 5 0 nt) of LI 80A TCS mutant in the first PGR of two-stepped 
sequential PGR. CTA of LI 80 was changed to GCG (Ala). 
5，TAT AAT TGC TAA ACT TGG CGC GAA GGT TTT GTC AAC ACG 3, 
TCS-N236A-F, forward primer that was used with TCS-CR to generate the 
C-terminal fragment (-50 nt) of N236A TCS mutant in the first PGR of two-stepped 
sequential PGR. AAC of N236 was changed to GCG (Ala). 
5，GCT GGA GTT GTA ACC TCC GCG ATC GCG TTG CTG CTG AAT 3’ 
TCS-N236A-R, reverse primer that was used with TCS-NF to generate the 
N-terminal fragment (-720 nt) of N236A TCS mutant in the first PGR of two-stepped 
sequential PGR. AAC of 1121 was changed to GCG (Ala). 
5, ATT CAG CAG CAA CGC GAT CGC GGA GGT TACAAC TCC AGC 3， 
,J 
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Primers for P2 and its truncation mutants 
P2-A^col-NF, forward primer that annealed at the N-terminus of the coding sequence 
of human P2. A methionine (ATG) was added at 5' end for translation initiation. 
+Ncol site. 
5，CAGGCCCATGG CGATG CGC TAG GTC GCC TCC 3’ 
V2-BamHl-CR, reverse primer that annealed at the C-terminus of the coding 
sequence of human P2. A stop codon (TAG) was added at 3' end for the termination of 
translation. +BamHl site. 
5，GAT GGATCC TTA ATC AAA AAG GCC AAA TCC 3 ’ 
F2Cl BamHl-CR, reverse primer that was used with P2-A^coI-NF for generating 
truncation mutant P2C1 with the last single amino acid deleted. A stop codon (TAG) 
was added to the 3' end for termination of translation. +BamHl site. 
5'TCGC GGATCC TTA AAA AAG ACC AAA GCC CAT 3 ‘ 
？2C2-BamHl-CR, reverse primer that was used with P2-A^coI-NF for generating 
truncation mutant P2C2 with the last single amino acid deleted. A stop codon (TAA) 
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was added to the 3' end for termination of translation. +BamHl site. 
5' TCGC GGATCC TTA A AG ACC AAA GCC CAT GTC 3' 
？2C3-BamHl-CR, reverse primer that was used with P2-A^coI-NF for generating 
truncation mutant P2C3 with the last single amino acid deleted. A stop codon (TAA) 
was added to the 3’ end for termination of translation. +BamHl site. 
5'TCGC GGATCC TTA ACC AAA GCC CAT GTC ATC 3 ‘ • 
？2C4-BamHl-CR, reverse primer that was used with P2-A^coI-NF for generating 
truncation mutant P2C4 with the last single amino acid deleted. A stop codon (TAA) 
was added to the 3’ end for termination of translation. +BamHl site. 
5, TCGC GGATCC TTA AAA GCC CAT GTC ATC ATC 3’ 
F2C5-BamHl-CR, reverse primer that was used with P2-NcoI-NF for generating 
truncation mutant P2C5 with the last single amino acid deleted. A stop codon (TAA) 
was added to the 3' end for termination of translation. +BamHl site. 
5'TCGC GGATCC TTA GCC CAT GTC ATC ATC AGA 3 ’ 
P2C11-BamHl-CR, reverse primer that was used with P2-A^c'oI-NF for generating • 
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truncation mutant P2C17 with the last singleamino acid deleted. A stop codon (TAA) 
was added to the 3’ end for termination of translation. +BamHl site. 
5, TCGC GGATCC TTA CTT CTC ATC TTT CTT CTC 3' 
P2C28-Bamin-CR, reverse primer that was used with P2-7VcoI-NF for generating 
truncation mutant P2C28 with the last single amino acid deleted. A stop codon (TAA) 
was added to the 3’ end for termination of translation. +BamHl site. 
5'CGA GGATCC TTA GC AG A ACC AGC AGC AGG 3, 
P2C46-Bamin-CR, reverse primer that was used with P2-A^coI-NF for generating 
truncation mutant P2C46 with the last single amino acid deleted. A stop codon (TAA) 
was added to the 3’ end for termination of translation. +BamHl site. 
5'CGA GGATCC TTA CCC ACC AGC AGG TAG ACT 3 ’ 
,-i 
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Chapter 3 Interaction between TCS and P2 
3.1 Introduction 
Trichosanthin (TCS), ricin A chain and pokeweed antiviral protein (PAP) belong to 
type I ribosomal inactivating protein (RIP) and possess N-glycosidase activity. They 
cleave the glycosidic bond of a single adenine base (A4324 of the tetraloop sequence 
GAGA) that is located in the highly conserved sarcin/ricin loop (SRL) of 28S rRNA of 
eukaryotic ribosome. Experiments show that rat rRNA in the context of the ribosome is 
depiirinated at A4324 by ricin A chain with a kcat nearly 10^-fold greater than that 
measured using naked 28S rRNA. Naked 23S rRNA of E. coli is also depiirinated by 
ricin A chain at the homologous N-glycosidic bond, A2660, at concentration similar to 
those effective on mammalian naked rRNA, yet ricin is ineffective against intact E. coli 
ribosomes [Endo and Tsurugi, 1987; Vater et al, 1995]. This indicates that the 
ribosomal proteins play an important role in making rRNA highly susceptible to the 
attack by RIPs. Ricin was found to bind with the mammalian ribosomal proteins L9 and 
LlOe by chemical cross-linking [Vater et al, 1995] and PAP was found to bind with 
ribosomal protein L3 by co-immunoprecipitation [Hudak et al, 1999]. 
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By yeast two-hybrid system, TCS was found to interact with human ribosomal proteins 
PO and PI [Chan et al, 2001]. Since the PO, PI and P2 form pentameric complex 
P0(P1-P2)2 at the lateral stalk of the large ribosomal subunits, all the cDNA sequences 
of three P-proteins were cloned and the interaction with TCS assayed. P2 was also 
found to interact with TCS by in vitro binding assay. 
In this study, P2 was employed as a model to study the interactions between P-proteins 
and TCS. From the preliminary NMR result, several suspected P2 interaction sites on 
TCS were found. They are 1121’ K173，R174, D176, K177, L180, K197, E210, R222, 
D229, N236 and R243 (Fig 3.1). The present study is focused on the hydrophobic 
residues 1121, LI80 and N236 and a double mutant K177AL180A. Alanine mutants 
were constructed by PCR using mutagenic primers. 
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Fig. 3.1 Suspected P2 interaction sites on TCS. They are 1121, K173, R174，D176, 
K177, L180, K197, E210, R222, D229, N236 and R243 locating on the surface near the 
C-terminal region. 
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3.2 Interaction between TCS and P-proteins in rat liver lysate 
The binding specificity of TCS with P-protein was assayed with rat liver lysate by in 
vitro binding assay. The rat liver was homogenized with homogenizing buffer (section 
2.11.5), the lysate was centrifuged at 15000 rpm (Beckman rotor, JA 30.5) for 30 
minutes at 4°C to remove the cell debris. The lysate supernatant (about 47 mg/ml 
protein) was saved and loaded to a TCS-coupled NHS column prepared as described in 
section 2.4.1. After washing with binding buffer, the proteins bound were eluted as the 
procedure described in section 2.4.2. The fractions collected were analyzed by Western 
blotting (section 2.10) using the anti-P antibodies (section 2.9) 
The results of the in vitro binding assay showed that all the three P-proteins, PO, PI and 
• P2, bound to the TCS-coupled NHS-column and P-proteins were detected in the elution 
fractions. The interaction of TCS and P-proteins is specific as TCS can fish out the 
P-proteins in the rat liver lysate (Fig. 3.2) 
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Fig. 3.2 Interaction of TCS and P-proteins by in vitro binding assay. 200 |al rat liver 
lysate supernatant was loaded to TCS-coupled NHS-activated resin, bound proteins 
were eluted by 1 M NaCl and detected by western blotting using anti-P antibodies. FT 
represented the flow-through fraction, Wl-4 and last W represented the wash fractions 
. 1 -4 and last wash fraction respectively, E1 -4 and last E represented elution 1 -4 and last 
elution respectively. Since the last common 17 amino acids residues of P-proteins were 
used to raise the anti-P antibodies, PO, PI and P2 were detected in the elution. 
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3.3 Construction of TCS mutants 
Alanine mutants of TCS were generated by PGR using wild-type TCS cDNA on pET8c 
as template. PGR was performed as described in section 2.1.5.3. The PGR products 
were analyzed by 1% TAE agarose gel for their expected size (section 2.1.3). They 
were gel-purified and recovered by Wizard SV Gel and PGR Clean-Up System from 
Promega (section 2.1.4). The recovered DNAs and vector, pET8c, were cleaved by 
Nco\ and BamHl for 2 hours (section 2.1.6), gel-purified and recovered by Wizard SV 
Gel and PGR Clean-Up System. The recovered insert DNAs were then ligated to the 
cleaved pET8c as described in 2.1.7. The ligation products were directly transformed to 
competent E. coli DH5a as described in section 2.1.1. The transformed bacteria were 
incubated at 37�C for 14-16 hours. Plasmid DNA was isolated from the bacterial 
“ colonies (section 2.1.2) and those containing DNA insert were screened by PGR 
reaction using primers TCS-NF and TCS-CR and by enzyme digestion (Fig 3.3). The 
confirmed clones were then sequenced by Macro gen Inc. 
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Fig 3.3 Restriction digestion of plasmids from the TCS mutants transformed colonies. 
The plasmids of TCS mutants (I121A, K177AL180A, LI80A and N236A) were 
screened by restriction enzyme digestion with Ncol and BamHl and analyzed by 1% 
agarose gel electrophoresis. The presence of a 750bp band indicated the presence of 
mutated TCS gene. TCS was also digested and acted as a positive control. 
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3.4 Expression and purification of TCS mutants 
The plasmid DNA containing the TCS and its mutated genes in the correct reading 
frame were transformed to competent E. coli BL21 (DE3) pLysS. TCS and mutants 
were expressed by E. coli BL21 (DE3) pLysS as described in section 2.2.1. After 
expression, the bacterial pellets were harvested and lysed to check for expression. TCS 
mutants had a higher soluble portion when it was expressed in 20�C. Expression profile 
of N236A at 20�C and 25�C are shown in Fig. 3.4. Therefore, TCS mutants were 
expressed in 20�C overnight. 
Both TCS wild-type and mutants were purified by loading the soluble fraction of the 
bacterial lysate to a CM-Sepharose column as described in section 2.2.2. The proteins 
were eluted at about 120-180mM NaCl (Fig. 3.5). After SDS-PAGE analysis, the 
fractions containing TCS or mutants were pooled and dialyzed against 20mM PB, pH 
6.5 extensively at 4 � C overnight and further purified by SP column (section 2.2.2). TCS 
or mutants were eluted at about 60-80mM NaCl (Fig. 3.6). The purification profile of 
K177AL180A was shown as an example. After SDS-PAGE analysis, the fractions 
containing purified TCS or mutants were pooled and the yield was about 10-12 mg/L 
bacterial culture. 
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Expression at 20°C Expression at 25oc 
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,, Fig 3.4 Expression profile of N236A at 20�C and 25�C. "BI" represents the cell 
culture before induction by IPTG, "Al" represents after induction, "lysate" represents 
whole lysate after sonication, "spt" represents the supernatant of lysate and "ppt" 
represents the insoluble fraction of lysate after centrifugation. Expression at 20°C 
increased the soluble fraction of TCS mutant. 
‘ . / 
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A) 
Elution profile of TCS K177AL180A by CM column 
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Fig. 3.5 Purification of TCS K177AL180Aby CM column. A) The elution profile of 
K177AL180A. K177AL180A eluted at about 120-180 mM NaCl. B) The fractions 
eluted were analyzed by 15% SDS-PAGE. The molecular weight of TCS mutant was 
about 27kDa and it showed a band in between the low molecular marker bands 20.1 and 
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Fig. 3.6 Purification of TCS K177AL180A by SP column. A) The elution profile of 
K177AL180A. K177AL180A was eluted at 60-80 mM NaCl. B) The fractions eluted 
were analyzed by 15% SDS-PAGE. The molecular weight of TCS mutant was about 
27kDa and it showed a band in between the low molecular marker bands 20.1 and 30 
kDa. "FT" represented the flow-through fraction, "F3-13" represented fractions 3 to 13. 
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3.5 Biological assay of TCS mutants 
The biological activities of TCS variants were assayed by cell-free translation system 
using rabbit reticulocyte lysate as a source of ribosome, mRNA and other endogenous 
factors for translation (section 2.5). The raw data were fitted to a logistic curve and the 
ID50, the concentration of protein to achieve 50% inhibition, of the mutated proteins 
were found. The abilities of the mutants to inhibit protein synthesis were compared by 
their ID50. 
In the assay, 100% translation was defined by the radioactive count of the control, 
assuming that bovine serum albumin does not inhibit protein synthesis. The raw data of 
the 0/0 translation were averaged and fitted to the following equation, which represents a 
logistic curve — a common curve type for dose-response curve: »� 
a 
V= •} � — + d 
1 x - c 
1 + e 
.I 
Where a = asymptotic maximum 
b= slope parameter 
c= value of x at inflection point 
d= asymptotic minimum 
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Fig. 3.7 Inhibition of protein synthesis by wild-type and mutated TCS. The protein 
•‘ synthesis was quantified by the amount of radioactive ^H-leucine incorporated into 
TCA precipitated substances. Radioactivity countings were done in triplicates. The 
assay was performed 3 times and error bars represent the standard deviation of the nine 
set of data. 
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IDso (nM) relative to TCS decrease in activity 
( m ) % no. of folds 
TCS 0.172 ±0.023 — — 
1121A 0.144 ±0.037 119.26 0.84 
K177AL180A 0.245 ±0.044 70.20 1.42 
L180A 0.192 ±0.010 89.63 1.12 
N236A 0.799 ±0.703 21.50 4.65 
Table 3.1 Summary of biological activity of wild-type and mutated TCS. There was no 
significant change in activity for mutants 112lA，K177AL180A and LI80A. For 
N236A, there was a about 4.65-fold decrease in activity comparing with wild-type 
TCS. 
All the mutants did not affect a great change in the decrease in activity. For mutants 
I121A, K177AL180A and LI80A, they had similar potencies as wild-type TCS. For 
N236A, there was a 4.65-fold decrease in activity. 
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3.6 Physical interaction of TCS and P2 by surface plasmon 
resonance (SPR) 
To study the importance of P2 binding of TCS to its biological activity, the physical 
interaction between wild-type and mutated TCS and P2 was studied by surface plasmon 
resonance (SPR) as described in section 2.8. 
Surface plasmon resonance (SPR) technique uses optical method to measure the 
refractive index near a sensor surface. The sample molecule (the ligand) is immobilized 
onto the sensor surface and its binding partner (the analyte) is injected in aqueous 
solution (sample binding buffer) through the flow cell under continuous flow. As the 
analyte binds to the ligand, the accumulation of protein on the surface results in an 
increase in the refractive index. The change in refractive index is measured in real time, 
and the results are plotted as response or resonance units (RUs) versus time (a 
sensorgram). By studying the binding at different concentration of analyte, the kinetics 
constant, Kd (equilibration dissociation constant), can be determined. 
The SPR experiments were performed using lAsys manual Biosensor system as 
described in section 2.8. Different concentrations of TCS wild-type and mutants were 
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applied to the P2-coupled aminosilane sensor surface (section 2.8.1). The data were 
analyzed using program lAsys FASTfit version 2.01. The schematic diagram showing 
the calculation of Kd from the SPR results is shown in Fig. 3.8. 
Special acknowledgement was addressed to my colleague, Miss Denise Chan, as the 
SPR results were part of her Ph.D project, and preliminary results were adopted to 
compare P2 binding and its effect on TCS biological activity. Affinity data of TCS and 
L180A is shown in Fig. 3.9-10 and Table 3.2. The affinity data of other TCS variants 
will be determined in the fiiture, and the results will be compared with the 
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Fig. 3.8 Schematic diagram showing how to obtain the Kd value from the SPR results. 
Total extent values of the interaction were plotted against the ligand concentration. 
When the total extent of the interaction is saturated and reached a maximum (Bmax)，the 




SPR results of P2-TCS interaction 
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Fig. 3.9 SPR results of P2-TCS interaction. Binding of TCS to immobilized P2 on the 
cuvette was a biphasic reaction, the total extent of TCS binding to P2 was plotted 
against TCS concentration. Data was analyzed by lAsys FASTfit program and fitted by 
binding curve equation. 
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SPR results of P2-TCSL180A interaction 
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Fig. 3.10 SPR results of P2-L180A interaction. Binding of LI 80A to immobilized P2 
on the cuvette was a biphasic reaction, the total extent of LI80A binding to P2 was 
plotted against LI80A concentration. Data was analyzed by lAsys FASTfit program 
and fitted by binding curve equation. 
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Kd (|iM) relative to TCS decrease in affinity 
(|iM) % no. of folds 
TCS 37.8 — — 
L180A ' 50.6 74.77 1.34 
Table 3.2 Summary of SPR results of binding of TCS and LI 80 A to P2. The affinity of 
L180A to P2 was similar to that of TCS wild-type. 
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3.7 Discussion 
Bindings of TCS with ribosomal P-proteins, PO, PI and P2 were demonstrated by yeast 
two-hybrid assay [Chan et al, 2001] and in vitro binding assay. Like other RIPs, 
bindings of ribosomal proteins may be crucial to TCS biological activity. As TCS is 
only active towards eukaryotic ribosomes, the distinct pentameric P-complex on the 
large ribosomal subunit may be important for kingdom specific, property of TCS 
activity. 
To study the interaction between TCS and P-proteins, P2 was employed as a model as it 
can be expressed in soluble form and the yield after purification is high. Also, our group 
is studying the interaction of TCS and P2 by NMR technique. The NMR study can help 
to find out the P2 interaction site on TCS so as to have a better understanding of TCS 
action mechanism. From the preliminary NMR data provided by my colleagues, several 
suspected P2 interaction site were identified, they are 1121, K173, R174，D176, K177, 
LI80，K197, E210, R222, D229, N236 and R243. They are located at the surface of 
TCS near the C-terminus (Fig. 3.1). These residues can be divided into two groups, one 
is the charged residues including K173, R174, D176，K177, K197, E210, D229 and 
R423，and another is the non-charged residues including 1121，L180 and N236. As my 
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colleagues were working with the charged residues, the present work focuses on the 
non-charged residues, 1121, LI80 and N236. Alanine mutants were constructed to 
figure out P2 interaction sites on TCS and the effect on its biological activity. As LI80 
are located closely to K177, a double mutant K177AL180A was also constructed and 
assayed (Fig. 3.11) 
From the results of ribosome-inactivating assay of TCS mutants, there was no 
significant decrease in activity. For mutants 1121A，K177AL180A and L180A, there 
was just around 0.8 to 1.4-fold decrease in ribosome-inactivating activity (Table 3.1). 
This showed that the mutations did not affect the ribosome-inactivating activity of TCS. 
This indicates that binding of P2 is not important to TCS activity or simply these 




Fig. 3.11 The four amino acid residues studied in the present study. Alanine mutants, 
1121A，K177AL180A, LI80A and N236A were constructed to study the interaction of 
7 7 
'� TCS with P2. 
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For N236A, there was a 4.65-fold decrease in ribosome-inactivating activity. N236 is 
not located at the active site of TCS. The mutation of N236A may interrupt the 
interaction between TCS and P2，leading to a decrease in activity. 
To study the correlation between P2 binding and ribosome-inactivating activity of TCS， 
surface plasmon resonance (SPR) was employed to investigate TCS-P2 binding. P2 
protein was immobilized on the cuvette surface, when proteins interacted with the 
immobilized P2, there was a change in refractive index and the kinetics of interaction 
can be determined. Preliminary SPR results of P2-L180A interaction showed that 
L180A had a 1.34-fold decrease in P2-binding comparing with TCS wild-type. The 
mutation did not affect the interaction with P2 and LI80 is not P2-interaction site. The 
results also confirmed the ribosome-inactivating activity assay of L180A that the 
mutation did not affect TCS activity. 
N236 appears to play some role in the binding to P2 and there is a drop of activity when 
it is mutated to alanine. The affinity of N236A with P2 will be determined by SPR to 
, further characterize the situation. 
,1 
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Chapter 4 Mapping the region of P2 that binds TCS and 
eEF2 
4.1 Introduction 
Both TCS and eEF2 bind P2. TCS was found to bind P2 by in vitro binding assay 
while eEF2 was found to interact with P2 by cross-linking with ribosome [Uchiumi et 
al, 1986] and surface plasmon resonance [Bargis-Surgey et al, 1999]. Then will the 
binding of TCS to P2 hinder the binding of eEF2 and thus inhibit protein synthesis? 
And would TCS compete with eEF2 for the same binding site on P2? 
The C-terminal regions of P-proteins are highly conserved. The last 17 C-terminal 
•>• th • • amino acid sequences are nearly identical (Fig. 4.1) except that the last 9 amino acid 
of PO is glutamate instead of aspartate in PI and P2. As both TCS and eEF2 bind 
P-proteins, the highly homologous C-terminal region of P-proteins may probably be 
the site of interaction. To map the interaction sites, the C-terminal region of P2 was 
systematically truncated and their interaction with TCS and eEF2 were assayed. 
“ 
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Fig. 4.1 Sequence alignment of the C-terminal region of human acidic ribosomal 
proteins, PO, PI and P2. The last 17 amino acid residues of P-proteins are nearly 
identical. (The dark grey colour represents identical amino acids, the light grey 
represents similar amino acids) 
I . • 
105 
4.2 Construction of P2 truncation mutants 
Truncation mutants of P2 were generated by PGR using wild-type P2 cDNA on 
pET8c as template. PGR was performed as described in section 2.1.5.3. The PGR 
products were analyzed by 1.5% TAE agarose gel for their expected size (section 
2.1.3). They were gel-purified and recovered by Wizard SV Gel and PGR Clean-Up 
System from Promega (section 2.1.4). The recovered DNAs and vector, pET8c, were 
cleaved by Ncol and BamHl for 2 hours (section 2.1.6)，gel-purified and recovered by 
Wizard SV Gel and PGR Clean-Up System. The recovered insert DNAs were then 
ligated to the cleaved pET8c as described in 2.1.7. The ligation products were directly 
transformed to competent E. coli DH5a as described in section 2.1.1. The transformed 
bacteria were incubated at 3TC for 14-16 hours. Plasmid DNA was isolated from the 
. bacterial colonies (section 2.1.2) and those containing DNA insert were screened by 
PGR reaction using primers P2-勤 I -NF and appropriate reverse primer and by 
enzyme digestion. The confirmed clones were then sequenced by Macrogen Inc. 
Cloning of P2 mutants, P2C46 and P2C28, were performed by my colleague, Mr. 
K.M. Lee. 
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4.3 Expression and purification of P2 truncation mutants 
The plasmid DNA containing the P2 and its mutated genes in the correct reading 
frame were transformed to competent E. coli BL21 (DE3) pLysS. P2 and mutants 
were expressed by E. coli BL21 (DE3) pLysS as described in section 2.2.1. After 
expression, the bacterial pellets were harvested and lysed to check for expression. All 
the P2 wild-type and mutants were expressed in soluble form and presented in the 
supernatant of the bacterial lysate. For P2 wild-type, the protein was purified at pH 
7.8 while the P2 mutants were purified at pH 8.5. 
Both wild-type and mutated P2 proteins were purified by loading the soluble fraction 
of the bacterial lysate to a DEAE-Sepharose column as described in section 2.2.3. The 
• proteins were eluted at about 200mM NaCl. The fractions containing P2 or mutated 
proteins were pooled after SDS-PAGE analysis. 
For P2 wild-type, P2C1, P2C2，P2C3, P2C4, P2C5 and P2C17, sodium chloride was 
added to the pooled fraction to a concentration of 2M. The proteins were further 
purified by HiTrap™ Phenyl HP column equilibrated with 20mM Tris, 2M NaCl pH 
7.8 or 8.5. The flow through fraction was collected and extensively dialyzed against 
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20mM Tris, pH 7.8 or 8.5 overnight at 4°C 
For P2C28 and P2C46, the pooled fractions from DEAE chromatography were 
concentrated to about 5ml and purified by gel filtration as mentioned in section 2.2.3. 
The fractions containing P2 mutant proteins were collected after SDS-PAGE analysis. 
P2 wild-type and mutants (except P2C46) were further purified by HiTrap^"^ Q 
column as described in section 2.2.3, while P2C46 was purified by HiTrap™ ANX 
column instead of Q. Proteins were eluted with 350ml 0-350mM linear NaCl gradient. 
After SDS-PAGE analysis, the purified protein fractions were collected and 
concentrated. The yield of wild-type and mutant P2 proteins could reach about 
30mg/L bacterial culture. 
All the purified P2 wild-type and mutants were analyzed by SDS-PAGE of which 
glycine in the electrophoresis buffer was replaced by tricine for a better stacking 
effect of low-molecular-weight P2C28 and P2C46 (Fig. 4.2) 
Secondary structures of P2 mutants were determined by circular dichroism 
spectrometry as described in section 2.6 (Fig. 4.3). All P2 truncation mutants have 
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similar molar ellipticity spectra when compared to P2 wild-type, showing that there is 
no major structural change in truncating the C-terminal region. 
LMW P2 P2C1 P2C2 P2C3 P2C4 P2C5 P2C17 P2C28 P2C46 
97 kDa 
66 kDai mm 
45 kDa 
30 kPai II " 
20.1 RDa 
14.4 kDa 
Fig. 4.2 SDS-PAGE analysis of purified P2 and mutants. The proteins were analyzed 
by 15% SDS-PAGE with tricine electrophoresis buffer. All wide-type and truncated 
P2 proteins were purified to over 95% purity. 
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CD spectrum of P2 wild-type and mutants 
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Fig. 4.3 The CD spectra of wild-type and mutated P2. 
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4.4 Mapping the region of P2 that binds TCS 
4.4.1 Interaction between TCS and P2 mutants by in vitro binding assay 
To study the interaction between TCS and P2 truncation mutants, in vitro binding 
assay was employed. Purified TCS was coupled to NHS-activated Sepharose resin 
(section 2.4.1) and purified P2 wild-type or mutants (200 yd of 50'|iM) were loaded to 
the 200 1^1 resin to assay for interaction (section 2.4.2). The resin was washed with 
over 25-bed volume to eliminate the non-specific binding. Bound protein was eluted 
with IM NaCl. Results are summarized in Fig. 4.4. 
To further confirm the interaction, wild-type and mutated P2 were coupled to 
• NHS-activated Sepharose resin (section 2.4.1) for binding with TCS and results are 
shown in Fig. 4.5. 
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Input LMW FT < wash ing—>< elation > Input LMW FT < washing > < elution > 
wmm 
a) TCS-NHS + P2 (positive control) b) TCS-NHS + P2C46 
LMW Input FT < -washing > < elution > Input FT LMW< washing > < elution > 
c) TCS-NHS + P2C28 d) TCS-NHS + P2C17 
LMW Input FT < -washing > < elution > LMW Input FT < washing > < elution > 
e) TCS-NHS + P2C5 f) TCS-NHS + P2C4 
Input LMW FT < washing-—-->< -elution -> Input LMW FT < washing >< -elution > 
_ I • • 
g) TCS-NHS + P2C3 h) TCS-NHS + P2C2 
< P2C1 > < P2C2 > 
LMW Input FT < washing >< elution > input FT <-washing-><--elution—> LMW Input FT <-washing-><-elution-> 
� � . � -
i) TCS-NHS+ P2C1 j) NHS + P2C1 or P2C2 (negative 
control.) 
Fig. 4.4 Summary of in vitro binding of P2 and its truncation mutants with 
TCS-coupled NHS resin (TCS-NHS for short). Fractions were analyzed by 15% 
SDS-PAGE. As P2 is an acidic protein, staining results by Coomassie Blue is not so 
sensitive, only faint bands were observed in elution (red box). P2C1 and P2C3 were 
found interacting with TCS-NHS (i & g). The experiments of in vitro binding assay of 
TCS with P2C1 and P2C3 had repeated 2 and 3 times respectively. The marker band 
of LMW shown is 14.4 kDa. 
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Fig. 4.5 Summary of in vitro binding of TCS and P2 or truncation mutants with 
P2/P2 mutants-coupled NHS resin (P2CX-NHS for short). Fractions were analyzed by 
15% SDS-PAGE. TCS bands observed in the elution indicated that TCS interacted 
with the P2 mutant coupled to NHS resin. TCS were found to interact with P2C1- and 
P2C3-NHS (red box). The marker band of LMW shown is 30 kDa. 
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The results of in vitro binding assay of TCS and P2 mutant are summarized in Fig 4.4 
and Fig. 4.5. P2 lost the interaction with TCS by deletion of the last four amino acid 
residues. This showed the last 4 amino acid residues are important for binding with 
TCS. 
Interestingly, P2C2 lost the interaction with TCS but P2C3 resumed TCS interaction. 
The reason for this phenomenon is unclear. Recently, the structure the of C-terminal 
last 13 amino acid residues of P2 has been solved by NMR technique [Scares et al, 
2004] (Fig. 4.6). The structure of P2 was still under resolution by my colleague using 
NMR technique. Resolution of three-dimensional structure of P2 may help to explain 
the interaction site with TCS. 
.1 
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Fig. 4.6 The structure of C-terminal last 13 amino acid residues of P2 (1S4J). The 
side-chain of last 5 amino acids were shown and labeled. 
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4.4.2 Interaction study of TCS and P2 mutant by isothermal titration 
calorimetry (ITC) 
Isothermal titration calorimetry (ITC) is a technique that can be used to measure the 
interaction enthalpy for almost any bimolecular process, provided that there is 
enthalpy change for the reaction. Thermodynamic profile of the interaction includes 
the association equilibrium constant (Kg), the number of binding sites (n), enthalpy 
(AH), entropy (AS), and free energy (AG). The schematic diagram showing how to 
obtain these thermodynamic parameters is shown in Fig. 4.7. To compare the binding 
constant of interaction between TCS and P2 wild-type or mutant, ITC was employed. 
About 1.5 ml 0.1 mM TCS was applied in the sample cell with twenty 5 of 1 mM 
P2/P2C5 injections as described in section 2.7. 
From the ITC results (Fig. 4.8 and Table 4.1)，the deletion of last 5 amino acid 
. residues weakened the interaction between TCS and P2. The dissociation equilibrium 
constant (Kd) of P2-TCS interaction was 45 ^M while the Kd of P2C5-TCS 
, interaction could not be determined as the result could not be analyzed due to the 
precipitation of samples during the experiment. This showed that the C-terminal 
amino acid residues o fP2 are important for TCS interaction. 
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Molar ratio ([liganci]/[macramoleclule]) 
AG = -RTIn(1/Kd) 
AG = AH -TAS 
.. Fig. 4.7 Schematic diagram showing how to obtain the thermodynamic parameters 
from the ITC result. The heat change during the injections ofligand to macromolecule 
was plotted against the molar ratio of lignand to macromolecule. From the plot, 
enthalpy (AH), association equilibrium constant (Ka) and binding ratio (n) can be 
determined. Besides, the free energy (AG) and entropy (AS) can also be calculated by 
the above formula. 
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ITC results of TCS with P2/P2C5 
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Fig. 4.8 ITC results of P2-TCS binding and P2C5-TCS binding. For P2-TCS 
binding, the sample cell contained 0.091mM TCS; 5[i\ injections of l.OlmM P2 were 
performed at 500 seconds intervals. For P2C5-TCS binding, the sample cell contained 
0.088mM TCS; 5\x\ injections of 0.76mM P2C5 were performed at 500 seconds 
intervals. The drop of the curve of P2C5-TCS reaction was due to the incomplete 
injection of sample. ‘ 
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P2-TCS P2C5-TCS 
n ^ ~ 
Ka (M—i) 22200 ™ 
Kd (laM) 45 — 
H (kJ/mol) ^ — 
Table 4.1 Comparison of thermodynamic data of P2-TCS and P2C5-TCS bindings. 
The KD of P2-TCS interaction was about 45|LIM while there was no interaction 
between P2C5 and TCS and the result could be analyzed. 
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4.5 Mapping the region of P2 that binds eEF2 
4.5.1 Purification of eEF2 from rat liver 
To study the interaction of eEF2 and P2, eEF2 was first purified from rat liver as 
described in section 2.3. About lOOg rat livers were homogenized, the lyaste was 
centrifuged and the supernatant was partially purified by ammonium sulfate 
precipitation. The ammonium sulfate precipitant was resuspended and extensively 
dialyzed to remove ammomium sulfate. Then dialyzed sample was purified by DEAE 
column and step eluted with 150mM KCL The fractions collected were analyzed by 
Western blotting (section 2.10) for the presence of eEF2 using 1:1000 dilution of 
goat-anti-EF2 antibodies as primary (Santa Cruz Biotechnology Inc., sc-13004). 
Rabbit-anti-goat IgG-HRP (Santa Cruz Biotechnology Inc., sc-2768) with a dilution 
of 1:1000 was used as secondary antibody. 
The eluate from DEAE column was purified by HiTrapTM Heparin column with 
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Fig 4.9 Purification of eEF2 by Heparin column. A) The elution profile of eEF2. 
eEF2 eluted at about 230-280 mM KCL B) Fractions were analyzed by 10% 
SDS-PAGE and C) by western blotting using anti-eEF2 antibodies. "FT" represents 
the flow-through fraction,”F 14-20” represented fraction 14 to 20. 
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The fractions containing eEF2 were pooled and concentrated to about 5ml for gel 
filtration chromatography using Seperdex™ 200. Elongation factor 2 was eluted at 
about 185ml (Fig. 4.10). Since there were still some impurities, the fractions were 
pooled and further purified by Mono Q column. (Fig. 4.11) The purified eEF2 was 
pooled, concentrated and stored at -20�C. About 2-3mg eEF2 were purified per lOOg 
rat liver. The purified eEF2 was confirmed by peptide mass fingerprinting by 
Professor S.M. Ngai's laboratory in Department of Biology (Fig. 4.12). 
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A) 
Elution profile of eEF2 by gel filtration 
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Fig. 4.10 Purification of eEF2 by gel filtration Superdex 200TM. A) The elution 
profile of eEF2 with 3ml per fraction.. B) Fractions were analyzed by 10% 
SDS-PAGE."F 17-24" represent fraction 17 to 24. 
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Fig 4.11 Purification of eEF2 by Mono Q. A) The elution profile of eEF2, blue line 
represented OD280, brown line represented the conductivity. B) Fractions were 
analyzed by 10% SDS-PAGE.，，F9-16，，represent fraction 9 to 16. 
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Fig.4.12 Result of peptide mass fingerprinting confirming the purified protein was 
eEF2 from rat livers. 
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4.5.2 Physical interaction of P2 and eEF2 by surface plasmon resonance 
(SPR) 
The dissociation equilibrium constant of P2-eEF2 interaction was studied by surface 
plasmon resonance (SPR). SPR was used instead of ITC to determine Kd because a 
large amount of protein (eEF2) was required for ITC. Besides, preliminary ITC 
experiment of P2-eEF2 interaction showed that proteins precipitated during ITC 
experiment (data not shown). Therefore, SPR was used to study P2-eEF2 interaction. 
Experiment was performed as described in section 2.8 and the results are shown in 
Fig. 4.13. 
About 0.61 ng P2/mm^ was immobilized on the aminosilane cuvette. Binding of eEF2 
to immobilized P2 on the cuvette was a biphasic reaction, total extent of eEF2 binding 
was plotted against eEF2 concentration. The data was fitted with the following 
equation. 
Bmax X [ L 
Specific binding = 
Kd + [ L ] 
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Where Bmax = maximum extent of binding 
[L] = concentration of ligand 
Kd = dissociation equilibrium constant 
The dissociation equilibrium constant (Kd) of P2-eEF2 interaction was 1.4 |j,M. 
SPR results of P2-eEF2 interaction 
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Fig. 4.13 SPR results of P2-eEF2 interaction. Binding of eEF2 to immobilized P2 on 
the cuvette was a biphasic reaction, the total extent of eEF2 binding to P2 was plotted 
against eEF2 concentration. Data were analyzed by lAsys FASTfit program and fitted 
by binding curve equation. 
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4.5.3 Interaction between eEF2 and P2 mutants by in vitro binding assay 
In coupling of eEF2 to NHS-activated Sepharose resin, the coupled eEF2 failed to 
interact with P2 (data not shown). eEF2 is a large protein with 858 amino acids, 
conformation of eEF2 may be destroyed during coupling and fail to interact with P2. 
Therefore, the interaction between eEF2 and P2 mutants were assayed by coupling P2 
mutants to NHS-activated Sepharose resin. The presence of eEF2 in the elution was 
detected by Western blotting using anti-EF2 antibodies for more sensitive results. 200 
[il of eEF2 sample was loaded to P2 mutant coupled resin and bound protein was 
eluted by 1 M NaCl after washing (section 2.4). Results are shown in Fig. 4.14. eEF2 
failed to interact with P2 mutants with deletion of one amino acid, thus, the 
C-terminal region of P2 is crucial for eEF2 interaction. 
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Input FT < washing >< oiiitinn - > Input FT < washing >< elution > 
I mil � � i T - w — 
a) P2-NHS + eEF2 (positive control) b) P2C46-NHS + eEF2 
Input FT < washing >< elution > input FT < washing >< "elution > 
c) P2C28-NHS + eEF2 d) P2C17-NHS + eEF2 
Input FT < washing >< elution > Input FT < washing ->< elution > 
e) P2C5-NHS + eEF2 f) P2C4-NHS + eEF2 
Input FT < washing >< elution > Input FT < washing >< elution > 
g) P2C3-NHS + eEF2 h) P2C2-NHS + eEF2 
Input FT < washing >< elution > Input FT < washing >< elution > 
— •mil I I , —• — 
i) P2C1-NHS + eEF2 j) NHS + eEF2 (negative control) 
Fig. 4.14 Summary of in vitro binding of eEF2 and P2 or truncation mutants with 
P2/P2 mutants-coupled NHS resin (P2CX-NHS for short). Fractions were analyzed by 
western blotting with 10% SDS-PAGE. eEF2 bands observed in the elution indicated 
that eEF2 interacted with the P2-coupled to NHS resin (red box). eEF2 failed to 
interact with all P2 truncation mutants. 
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4.6 Mapping the C-terminal region of P2 by MBP-fusion 
proteins 
Since eEF2 failed to interact with P2 mutants even with one amino acid deleted, 
different C-terminal regions of P2 were cloned with MBP-fusion vector (pRMBP) to 
generate MBP-fusion proteins for mapping the C-terminal region of P2 that binds 
with eEF2. Besides, the generation of MBP-fusion proteins can help to confirm the 
interaction site of P2 for TCS binding and act as a positive control for in vitro binding 
assay of the MBP-fusion proteins. 
For generation of MBP-fusion proteins, a thrombin cutting site LVPR|GS was 
introduced between MBP and target protein. To minimize the influence of extra GS 
residues after thrombin cleavage, the C-terminal region of P2 started with GS 
sequence was cloned at the C-terminal of MBP (last 36 amino acids and last 29 amino 
acids). Besides, the peptide of the C-terminal last 17 amino acid residues was also 
cloned to generate MBP-C17 protein to further confirm the interaction of C-terminal 
ofP2 with TCS. 
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4.6.1 Construction and purification of MBP-fusion proteins 
The clones of MBP-C36, MBP-C29 and MBP-C17 were provided by my colleague, 
Mr. K.M. Lee. Fig. 4.15 shows the sequences of amino acid cloned with MBP-fusion. 
MBP-fusion proteins were purified as described in section 2.2.4 with over 85% purity. 
Purification profile of MBP-C29 is shown in Fig. 4.16 as an example. 
1 0 2 0 3 0 
I . . . . I I I I I I . 
C36 of P2 AAPAAGSAPl a M e K K D E K K ^ S E E S D D D H GFGLFD 3 6 
C29 of P2 A^IJ AAEEKKDEKI^  EESEESDDDM G^GLFD 29 
C17 of P2 — — - - - K EESEESDDDIi GFGLFI^ 17 
Fig. 4.15 The C-terminal sequences of P2 cloned with MBP-fusion. Two extra GS 
residues would be added in N-terminal of peptide after thrombin cleavage. 
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A) 
Elution profile of MBP-C29 purification 
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Fig. 4.16 Purification of MBPC29 protein by Copper�— chelating resin. A) Elution 
profile of MBPC29. B) Fractions were analyzed by 12.5% SDS-PAGE. The purified 
MBPC29 had over 95% purity. FT" represents the flow-through fraction,，，F23-33，’ 
represent fraction 23 to 33. 
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4.6.2 Interaction among eEF2, TCS and MBP-fusion proteins by in vitro 
binding assay 
Purified MBP-fusion proteins, MBP-C36，MBP-C19 and MBP-C17, were coupled to 
NHS-activated Sepharose resin for in vitro binding assay. 200fj.l TCS or eEF2 was 
loaded to 200 coupled resin and bound protein was eluted with IM NaCl as 
described in section 2.4. MBP protein was also coupled to NHS-activated resin as the 
negative control. The interaction of TCS with the C-terminal region of P2 was further 
confirmed by the in vitro binding assay with MBP-C36, MBP-C29 and MBP-C17. 
TCS bound to all three proteins coupled resin (Fig. 4.17). 
However, eEF2 was just detected in the elution of assay with MBP-C36 coupled resin 
showing that the interaction between eEF2 and P2 required the last 36 amino acid 
residues of P2. Both last 29 and last 17 amino acids showed no interaction with eEF2 
as no eEF2 was detected in the assay with MBP-C29 and MBP-C17 resins (Fig. 4.18) 
.1 
133 
LMW Input FT < washing——-->< elution 了> Input FT LMW< washing >< glution •> 
^ I I • I 
a) MBPC17-NHS + TCS b) MBPC29-NHS + TCS 
LMW Input FT < washing . x •.••elution LMW Input FT < washing >< elution > 
、 “ 一 
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c) MBPC36-NHS + TCS d) MBP-NHS + TCS (negative control) 
Input FT LMW < w a s h i n g — ‘ -glutlon- ---丁、 LMW Input FT < washing >< elution > 
� 
e) TCS-NHS + MBPC17 f) TCS-NHS + MBP (negative control) 
Fig. 4.17 Summary of in vitro binding of TCS with MBP-fusion proteins. Fractions 
were analyzed by 15% SDS-PAGE. TCS bands observed in the elution of 
MBP-C17-NHS, MBP-C29-NHS and MBP-C36-NHS indicated that TCS interacted 
with the MBP-fusion proteins coupled to NHS resin (red box, a-d). The marker band 
of LMW shown in (a-d) was 30 kDa. MBP and MBP-C17 were loaded to TCS-NHS 
for binding, MBP-C17 was detected in the elution (red box, e). The marker band of 
LMW shown in (e) and (f) was 45 kDa. (d) and (f) were the negative control of the 
experiments. 
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Input FT < washing >< elution > Input FT < washing >< elution > 
� � � " " -
a) MBP-C17-NHS + eEF2 b) MBP-C29-NHS + eEF2 
Input FT < washing >< -glutiPn --> Input FT < washing——>< -«lution > 
c) MBP-C36-NHS +eEF2 d) MBP-NHS + eEF2 (negative control) 
Fig. 4.18 Summary of in vitro binding assay of eEF2 with MBP-fusion proteins 
coupled to NHS resin. Fractions were analyzed by western blotting with 10% 
SDS-PAGE. eEF2 was detected only in binding with MBP-C36-NHS (red box). 
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Interaction with TCS Interaction with eEF2 
P2 I + + 
P2C1 I + _ 
P2C2 I - _ 
P2C3 I + -
P2C4 ~ ~ I - _ 
P2C5 ~| - _ 
P2C17 I _ _ 
P2C28 ~1 - -
P2C46 I - -
I MBP I . 」 C I7 + -
zzizzr ‘ — — — 
MBP J i C291 + _ 
MBP I— C36 + + 
Fig. 4.19 Overall summary of in vitro binding assays of P2 mutants and MBP-fusion 
proteins with TCS or eEF2. Positive interaction is represented by "+" whereas 




Both TCS and eEF2 bind P2. Mapping the interaction sites of P2 with TCS or eEF2 
may reveal if they are the same. In vitro binding assay was employed to map the 
interaction sites on P2 that binds TCS or eEF2. Since the C-terminal regions of 
P-proteins are highly conserved, this suggests that it is the site of interaction with 
eEF2 and/or TCS. To map the interaction site of P2, the C-terminal region was 
systematically truncated and the interaction with TCS or eEF2 was assayed. 
P2 truncation mutants, P2C46 and P2C28, were firstly constructed, purified and 
assayed with the binding of TCS and eEF2. Both TCS and eEF2 no long interact with 
P2C46 and P2C28. This further confirmed that the interaction site ofP2 with TCS and 
eEF2 'is located in the C-terminal region. Then other P2 truncation mutants were 
constructed. 
The C-terminal 17 amino acids among P-proteins are almost identical (Fig. 4.1). It is 
believed that the conserved sequence plays an important role in binding with 
elongation factors and TCS. P2C17 lost the interaction with TCS and eEF2 in the in 
vitro binding assay. Further experiments were carried out to find out the minimum . 
137 
region of P2 that are required for the TCS and eEF2 interaction. 
The C-terminal amino acid was deleted one by one up to the last 5 amino acids. P2C5, 
P2C4, P2C3, P2C2 and P2C1 were constructed and purified. The deletion of 5 or 4 
C-terminal residues of P2 abolished the interaction with TCS. Interestingly, deleting 3 
and 1 amino acid residues retained the interaction but P2C2 did not interact with TCS. 
Reason for this phenomenon is unclear. This may be due to the deletion of last 2 or 3 
residues adopted different local conformation at C-terminal region. Certain 
conformation of C-terminal region is required for interaction with TCS. Therefore, 
P2C2 abolished interaction with TCS while P2C3 retained the interaction. 
Recently, the NMR structure of synthetic peptide of last 13 C-terminal residues has 
been published (1S4J) [Scares et al, 2004]. This may help to understand the 
conformation of C-terminal region of P2 and structural basis of interaction with TCS. 
. However, the structure published is just the structure of the synthetic peptide, it may 
not be the real conformation as in the full-length P2 protein. The resolution of NMR 
structure of P2 wild-type may help to figure out the interaction site of P2 with TCS. 
Isothermal titration calorimetry (ITC) was employed to study the dissociation , 
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equilibrium constant of P2-TCS interaction. Dissociation equilibrium constant (Kd) is 
a parameter to show the affinity of ligand to its interaction partner. The lower Kd, the 
stronger affinity. The interaction of P2 and TCS is an exothermic reaction, heat 
changes were measured and Kd could be determined. Kd of P2-TCS interaction was 
about 45 jiM while there is no interaction between P2C5 and TCS. This revealed that 
the 5 C-terminal residues play an important role in the interaction with TCS. 
Surface plasmon resonance (SPR) is another technique to measure Kd by detecting the 
change of refractive index after binding of analyate to immobilized ligand. For the 
interaction between P2 and TCS, both techniques, SPR and ITC, were used. The Kd 
values of the interaction measured by SPR and ITC were about 38|iM and 45 \xM 
respectively. Both values obtained were in micro-molar range showed that the Kd 
measurement was reliable. To compare the results from the two experiments, the 
result from ITC was more reliable as both proteins (P2 and TCS) were in native form 
in the solution without immobilization or coupling. Thus the unwanted steric effects 
due to immobilization of protein on the senor chip surface affecting Kg value were 
eliminated. However, there are also limitations for ITC, one is the heat change during 
the interaction must be detectable by the instrument, and the other is that ligand 
requires a high solubility to carry out the experiment. , 
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Surface plasmon resonance was employed to find out Kd of P2-eEF2 interaction as 
less protein was required compared with ITC. The Kd of P2-eEF2 interaction 
determined by SPR was 1.4 }iM which is 10-fold stronger than that of P2-TCS 
interaction. The Kd value obtained was similar to the literature value (2.2 |iM 
[Bargis-Surgey et al, 1999])，the difference was due to coupling of different proteins 
on the sensor chip. The experiment in the literature used the sensor chip coupled with 
eEF2 while the P2-coupled senor chip was used in this project and this might affect 
the Kd calculated. 
By in vitro binding assay, eEF2 lost the interaction with P2 with deletion of the last 
C-terminal residue. This indicated that the whole C-terminal region ofP2 is important 
for P2-eEF2 interaction. To map the minimum region of P2 C-terminus that is 
required for binding with eEF2, different C-terminal regions of P2 were fused with 
MBP for 
in vitro binding assay. From the results shown in Fig. 4.19’ eEF2 bound with 
MBP-C36 protein while no interaction was detected with MBP-C29 and MBP-C17 
proteins. This showed that the sequence of C-terminal 36 amino acids (C36) is likely 
to be crucial in P2-eEF2 interaction. This also explained the reason of why the 
interaction between P2 and eEF2 was 10-fold stronger than that of P2-TCS interaction . 
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as more residues on P2 were required for interaction with eEF2 than TCS. 
In the sequence of C36 of P2, there are two repetitive AP-rich sequence while there is 
just one AP-rich sequence found in C29 (Fig. 4.20). These two AP-rich sequences 
may be the recognition site for docking of eEF2 to P2. 
C3 6 o f P2 AAPAAGSAPAAAEEKKDEKKEESEESDDDMGFGLFD 
C2 9 o f P2 APAAAEEKKDEKKEESEESDDDMGFGLFD 
Fig. 4.20 Sequences of C36 and C29 of P2 with AP-rich sequences highlighted. 
Similar repetitive AP-rich sequences are also found in the C-terminal region of PO and 
PI (Fig. 4.21) showing the sequences may be important for interaction with 
elongation factors. 
PO AAAPVAAATTAAPAAAAAPAKVEAKEESEESDEDMGFGLFD 
P I AAPAGGPAPSTAAAPAEEKKVEAKKEESEESDDDMGFGLFD 
P2 APGSAAPAAGSAPAAAEEKKDE-KKEESEESDDDMGFGLFD 
Fig. 4.21 Sequences of C-terminal region of PO, PI and P2 with AP-rich sequences 
highlighted. 
Binding of TCS to P2 may hinder the interaction with eEF2 as binding of TCS 
would "mask" the eEF2 interaction site on P2 and affect eEF2 binding. As a result, 
TCS may inhibit protein synthesis by masking the eEF2 binding site on P2 preventing 
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the binding of eEF2 to ribosome for its function. 
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Chapter 5 Effect of C-17 peptide on TCS biological activity 
5.1 Introduction 
By in vitro binding assay, the highly conserved C-terminal region of P-proteins was 
found to be the interaction site with TCS. To study the effect of the C-terminal region 
of P-proteins on TCS biological activity, C-terminal last 17 amino acids (C-17) 
peptide was added to the in vitro protein synthesis system. The N-acetylated C-17 
peptide with over 90% purity was purchased from Peptron Inc. The sequence of C-17 
peptide is shown in Fig. 5.1. 
N' KEESEESDDDMGFGLFD C 
“ . Fig. 5.1 Sequence of C-17 peptide. 
The effect of C-17 peptide in the ribosome-inactivating assay was studied. Different 
concentrations of C-17 peptide (lO'"^  to 10^ nM) were assayed (section 2.5). The effect 
of C-17 peptide is shown in Fig 5.2. 
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"Fig. 5.2 Inhibition of protein synthesis of C-17 peptide. The protein synthesis was 
quantified by the amount of radioactive leucine incorporated into TCA precipitated 
substances. Radioactivity countings were done in triplicates. Error bars represent the 
standard deviation of data. 
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5.2 Ribosome-inactivating activity of TCS with C-17 peptide 
The C-17 peptide was first pre-incubated with rabbit reticulocyte lysate. The final 
concentration of C-17 peptide in the system was 0.1 mM which was in great excess 
when compared with TCS concentration (10""^  to lO^nM). The ID50 of TCS in the 
presence C-17 peptide was compared with that without C-17 peptide to study the 
effect of C-17 peptide on TCS activity (Fig. 5.3). 
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Effect of C-17 peptide on TCS activity 
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Fig. 5.3 Inhibition of protein synthesis by TCS in the presence/ absence of C-17 
peptide. The protein synthesis was quantified by the amount of radioactive leucine 
incorporated into TCA precipitated substances. Radioactivity countings were done in 
triplicates.The assay was performed 2 times and error bars represent the standard 
deviation of data. 
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5.3 Discussion 
The C-terminal regions of P-proteins are highly conserved and the last 17 amino acid 
residues are nearly identical. By in vitro binding assay, the C-terminal region of P2 
was found to be important for binding with TCS. As TCS interacts with PO, PI and P2, 
the C-terminal end of P-proteins is believed to be the putative TCS interaction site. 
Peptide of the last 17 amino acid residues was synthesized to study if it can affect 
TCS activity. Before binding with TCS, the effect of C-17 peptide on protein 
synthesis was assayed. Different concentration of C-17 peptide was added to the 
rabbit reticulocyte lysate and percentage of protein synthesis was measured by the 
amount of radioactive leucine incorporated into TCA precipitated substances. The 
results are shown in Fig. 5.2: 
The preliminary results showed that C-17 peptide decreased protein synthesis by 
20-30% but no dosage dependent manner was observed. In a high concentration (0.1 
mM) of C-17 peptide, the percentage of protein synthesis was about 50% of the 
control. C-17 peptide may interact with ribosomal components and translation factors 
in the lysate and cause a decrease in protein synthesis. 
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To ensure the concentration of C-17 peptide was in great excess compared with TCS 
to account for the possibility that C-17 peptide may also interact with other cellular 
components, a high basal concentration of peptide (0.1 mM) was applied in the assay 
7 1 
while TCS concentration ranged 10" to 10 nM. 
Fig. 5.3 shows the results of the effect of C-17 peptide on TCS biological activity. The 
percentage of protein synthesis of TCS in the presence of C-17 peptide was compared 
with the BSA control with 0.1 mM peptide. It was shown that C-17 peptide had no 
effect on TCS ribosome-inactivating activity. There may be several reasons. First, the 
P2 binding site of TCS is different from the catalytic site, binding of the peptide 
would not hinder the catalytic action of TCS and thus has no effect on TCS activity. 
Second, the Kd of TCS and C-17 peptide need to be determined to find out whether 
‘binding of TCS to C-17 is too weak. Third, Western blotting should be performed to 
prove whether C-17 peptide in the experimental lysate was degraded or not. 
Nevertheless, the experimental results indicated that the binding of C-17 peptide was 
not important for TCS biological activity. There was no effect on the TCS biological 
‘ . 1 
activity in the presence of C-17 peptide. 
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Chapter 6 Conclusion and suggestions for future study 
The present work has shown the interaction among TCS, P2 and eEF2 by several 
techniques including site-directed mutagenesis, in vitro binding assay, 
ribosome-inactivating assay using rabbit reticulocyte lysate in vitro system, 
isothermal titration calorimetry and surface plasmon resonance. 
By site-directed mutagenesis, proposed P2 interaction sites on TCS were mutated to 
alanine and the ribosome-inactivating activities of the TCS variants were assayed. 
Assay results were compared with the affinity data by surface plasmon resonance with 
immobilized P2. It was found that LeulSO of TCS was not involved in interacting 
with P2, and LI 80A showed no effect on ribosome-inactivating activity of TCS. Other 
alanine mutants, I121A, K177AL180A and N236A, also showed little or no effect on 
TCS activity. Besides these four residues, other suspected charged residues on TCS 
surface were also studied by our group. K173, R174 and K177 showed a drop in 
binding with PO by yeast two-hybrid system and their ribosome-inactivating activities 
were also decreased (unpublished data). Interaction between TCS and the pentameric 
P-complex will be studied as a final goal as reconstitution of P-complex is in progress 
by our group. 
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TCS interaction site on P2 was mapped by truncation of P2 protein and in vitro 
binding assay. The last 5 C-terminal residues of P2 were important for TCS binding. 
This agrees with the suggestion that the N-terminal domains of PI and P2 are for the 
assembly of ribosomal stalk complex [Gonzalo et al, 2001]. However, the deletion of 
the conserved end of PO does not lose the interaction with TCS. Deletion of 
C-terminal 44 amino acids on PO retains the interaction with TCS mutant 
E160A-E189A by yeast two-hybrid system, and the minimum region of PO to interact 
with TCS is amino acids 220-273 [Chan et al, 2001]. This raises the interest that TCS 
binds to different regions of P-proteins on the stalk. The minimum region of P2 for 
TCS interaction will be mapped by fusion of P2 C-terminal residues to MBP protein. 
" B y bqth in vitro binding assay and NMR experiment observation, the C-terminal 
region of P2 is important for TCS interaction. However, a peptide containing the last 
17 C-terminal amino acid of P2 has no inhibitory effect on TCS ribosome inactivation 
activity in an in vitro protein synthesis system. Introduction of P-proteins (PO, PI, P2 
or whole P-complex) to the in vitro protein synthesis system may be performed to 
study the effect of P-protein on TCS ribosome-inactivating activity. 
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The kingdom specificity of eEF2 action was demonstrated by hybrid ribosome 
experiments with the prokaryotic ribosomal stalk proteins replaced by their eukaryotic 
counterparts PO, PI and P2 [Uchiumi et al, 2002a and b]. As N-glycosidase activity of 
TCS is specific to eukaryotic ribosome, the hybrid ribosome experiment can be used 
to study the importance of P-proteins in TCS biological activity. 
By in vitro binding assay, the last 36 amino acids of C-terminal region of P2 have 
been shown to be important for binding with eEF2. As docking to ribosome is an 
essential step for the function of eEF2 in protein synthesis, mapping the eEF2 
interaction site on P2 or other P-proteins helps to understand the protein synthesis 
machinery. The structure of yeast eEF2 has been solved by protein crystallography 
recently [Jorgensen et al, 2003]. By co-crystallization of yeast eEF2 and P2 (or the 
- l a s t 36 residues), the sites of interaction of both proteins can be found out. Preliminary 
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Al DNA and amino acid sequence of TCS 
1 gat gtt age ttc cgt tta tea ggt gca aca age agt tcc tat gga 45 
1 D V S F R L S G A T S S S Y G 15 
46 gtt ttc att tea aat ctg aga aaa get ctt cca aat gaa agg aaa 90 
16 V F I S N L R K A L P N E R K 30 
91 ctg tac gat ate cct ctg tta cgt tcc tct ctt cca ggt tct caa 135 
31 L Y D I P L L R S S L P G S Q 45 
136 cgc tac gca ttg ate cat ctc aca aat tac gcc gat gaa acc att 180 
46 R Y A L I H L T N Y A D E T I 60 
181 tea gtg gcc ata gac gta acg aac gtc tat att atg gga tat cgc 225 
61 S V A I D V T N V Y I M G Y R 75 
226 get ggc gat aca tcc tat ttt ttc aac gag get tct gca aca gaa 270 
76 A G D T S Y F F N E A S A T E 90 
271 get gca aaa tat gta ttc aaa gac get atg cga aaa gtt acg ctt 315 
—91 . A A K Y V F K D A M R K V T L 105 
316 cca tat tct ggc aat tac gaa agg ctt caa act get gca ggc aaa 360 
106 P Y S G N Y E R L Q T A A G K 120 
361 ata agg gaa aat att ccg ctt gga ctc cct get ttg gac agt gcc 405 
121 I R E N I P L G L P A L D S A 135 
406 att acc act ttg ttt tac tac aac gcc aat 'tct get gcg teg gca 450 
136 I T ' T L F Y Y N A N S A A S A 150 
451 ctt atg gta ctc att cag teg acg tct gag get gcg agg tat aaa 495 
. 1 5 1 L M V L I Q S T S E A A R Y K 165 
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496 ttt att gag caa caa att ggg aag cgt gtt gac aaa acc ttc eta 540 
166 F I E Q Q I G K R V D K T F L 180 
541 cca agt tta gca att ata agt ttg gaa aat agt tgg tct get ctc 585 
181 P S L A I I S L E N S W S A L 195 
586 tcc aag caa att cag ata gcg agt act aat aat gga cag ttt gaa 630 
196 S K Q I Q I A S T N N G Q F E 210 
631 agt cct gtt gtg ctt ata aat get caa aac caa cga gtc acg ata 675 
211 S P V V L I N A Q N Q R V T I 225 
676 acc aat gtt gat get gga gtt gta acc tcc aac ate gcg ttg ctg 720 
226 T N V D A G V V T S N I A L L 240 
721 ctg aat aga aac aat atg gca taa 744 
241 L N R N N M A * 247 
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A2 DNA and amino acid sequences of P2 
1 ATG CGC TAG GTC GCC TCC TAG CTG CTG GCT GCC CTA GGG GGC AAC 45 
1 M R Y V A S Y L L A A L G G N 15 
46 TCC TCC CCC AGC GCC AAG GAC ATC AAG AAG ATC TTG GAC AGC GTG 90 
16 S S P S A K D I K K I L D S V 30 
91 GGT ATC GAG GCG GAC GAC GAC CGG CTC AAC AAG GTT ATC AGT GAG 135 
31 G I E A D D D R L N K V I S E 45 
136 CTG AAT GGA AAA AAC ATT GAA GAC GTC ATT GCC CAG GGT ATT GGC 180 
46 L N G K N I E D V I A Q G I G 60 
181 AAG CTT GCC AGT GTA CCT GCT GGT GGG GCT GTA GCC GTC TCT GCT 225 
61 K L A S V P A G G A V A V S A 75 
226 GCC CCA GGC TCT GCA GCC CCT GCT GCT GGT TCT GCC CCT GCT GCA 270 
76 A P G S A A P A A G S A P A A 90 
271 GCA GAG GAG AAG AAA GAT GAG AAG AAG GAG GAG TCT GAA GAG TCA 315 
91 A E E K K D E K K E E S E E S 105 
316 GAT GAT GAC ATG GGA TTT GGC CTT TTT GAT TAA ATT CCT GCT CCC 360 
106 ‘、D D D M G F G L F D * I P A P 120 
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A3 Vector map of pETSc 
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Afllll (215l) 
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8511107 1 (25~:1) 
B, ,,A 1(2rJl14/ 
pET-3a 
(4G40bp) 
Tth 111 1(24Ui) 
BsmBI( 23!JJ) 
PVII1I(2343) 





~ TT promoter , • Xba I rbs 
AGATCTCGATCCCGCGAAA TT AATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAA T AA TTTTGTTT AACTTT AAGAAGGAGA 
Ncle I T1·Tag pET- 30 ?"!'.T!I::i..! ~e~~,~,~? .. ! 
TAT ACA T A TGGCTAGCATGACTGGTGGACAGCAAATGGGTCGCGGA TCCGGCTGCTAACAAAGCCC'GAAAGGAAGC TGACTTGGCTGCTGCCAC~CTGAGCAA T AACT AGCAT AA 
MetA I oSerl1etThrG I yG I y~ I nG I nMetG I yArgG I ySerG I yCysEnd T7 terminator orimer #69337.3 
pET - 3d 
Nc:a I 
pET - 3b , ' , GGTCGGGATCCGGCTGCT AACAAAGCCCGAAAGGAAGC TG AG TTGGCTGCTGCCACCGC TGAGCAA T AACTAGCATAA 
. , . G lyArgAspP r oA I oA I oAsnLysA I oArgLysG I uA l oG I uLeuA I oA I oA I oThrA I oG I uG I nEnd 
, TACCATGGCTAGC , , 
Met A loSer ', , 
pET - 3c.d , , , GGTCGGA TC C,GGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAAT AAC T AGCA T AA 
. , . G I yArq II eArqLeuLeuThrLyaf.'roG I uArqLyaLeuSerTrpLauLeuProP r oLeuSerAsnAanEnd 
T1 terminator 
CCCCTTGGGGCCTCtAAACGGGTCTTGAGGGGTTTTT'tG 
pET-3a-d cloning/expression region 
The pET8C (pET-3d) vector map is showed above. It includes T7 promoter, 
RBS, T7-Tag, ATG, MCS, T7 terminator and ampicillin resistance gene. The 
details ofMCS (cloning / expression region) is showed below the map. 
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